Top

Maria A. Lopez-Olivo, M.D., M.Sc., Ph.D.

Department of Health Services Research, Division of Cancer Prevention and Population Sciences

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Health Services Research, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX

Director, Department of Cochrane US Affiliate The University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, Houston, TX

Research Interests

I am a health services researcher specializing in evidence synthesis and knowledge translation, with a focus on autoimmune diseases, rheumatic conditions, and their associations with cancer. My work applies systematic reviews, meta-analyses, and evidence appraisal to support clinical guideline development and healthcare decision-making. As the Director of Cochrane Activities at MD Anderson, I oversee systematic review initiatives and mentor researchers in evidence synthesis methodologies. My knowledge translation efforts have focused on developing and evaluating educational tools for patients and summarizing evidence for healthcare providers through Cochrane summaries. I have also conducted environmental scans of online health resources and assessed physician perspectives on clinical practices to enhance the accessibility and usability of synthesized evidence in clinical settings.

Education & Training

Degree-Granting Education

2005	Universidad de Guadalajara, Guadalajara, US, Ph.D. in Clinical Pharmacology
2003	Universidad de Guadalajara, Guadalajara, MX, M.S. in Pharmacology
2001	Universidad de Guadalajara, Guadalajara, MX, MD

Postgraduate Training

2022-2022	Early Investigator Advancement Program, National Cancer Institute Equity and Inclusion Program
2021-2021	Mentorship and Leadership on Cancer-related Health Disparities Program, National Cancer Institute Awardee Skills Development Consortium, Houston, Texas
2021-2021	Academic Career Skills: Leadership, Collaboration, and Resilience, National Cancer Institute Awardee Skills Development Consortium, Houston, Texas
2020-2020	Training Institute for Dissemination and Implementation Research in Cancer, The National Cancer Institute Division of Cancer Control and Population Sciences, Houston, Texas
2016-2018	Certificate, Foundational Aspects of Medical Decision Making, Core Course Curriculum, Society for Medical Decision Making
2008-2010	Certificate, Clinical Research, University of Texas Medical School at Houston, Houston, Texas
2006-2010	Postdoctoral Fellowship, The University of Texas MD Anderson Cancer Center, Houston, Texas
2005-2006	Research Fellowship, Health Services Research, Baylor College of Medicine, Houston, Texas
2002-2005	Residency, Rheumatology-Research, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco
2001-2002	Certificate, Toxicology, Colegio de Toxicologia del Estado de Jalisco, Guadalajara, Jalisco
2000-2001	Certificate, Bioethics, Centro Universitario en Ciencias de la Salud, Guadalajara, Jalisco
1999-2000	Clinical Internship, Secretaria de Salud, Guadalajara, Jalisco

Experience & Service

Academic Appointments

Assistant Professor, Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2021

Assistant Professor, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2019

Instructor, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2013

Other Appointments/Responsibilities

Chair, Development of the ACR/EULAR classification criteria for Immune Related Inflammatory Arthritis, OMERACT, Houston, Texas, 2022 - Present

Director, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present

Institutional Committee Activities

Member, Department Wellness Leads, 2024 - Present

Member, Executive Committee of the Faculty Senate (ECFS), 2023 - Present

Member, Mid-Career Faculty Committee, 2023 - Present

Senator, MD Anderson Cancer Center Faculty Senate, 2022 - Present

Member, MD Anderson Cancer Center Faculty Senate Risk Detection and Outcomes Program MD Anderson’s Cancer Center Support Grant (CCSG), 2022 - Present

Member, Division of Cancer Prevention and Population Sciences Diversity and Inclusion Initiative - Advisory Committee, 2020 - 2023

Member, Institutional Review Board 2 Committee, The University of Texas MD Anderson Cancer Center, 2012 - 2013

Member, Psychosocial, Behavioral, and Health Services Research Committee, The University of Texas MD Anderson Cancer Center, 2012 - 2015

Member, Division of Internal Medicine Research Committee, The University of Texas MD Anderson Cancer Center, 2010 - 2012

Member, Bioethics and Research Committee, Instituto Mexicano del Seguro Social Hospital General Regional 110, 2002 - 2004

Honors & Awards

2026 - 2027	National Researcher Level 1, CONACyT – Mexican Council for Science and Technology
2024	Poster Finalist 2024 Professional Development Workshop, National Cancer Institute
2022	Nominated for the 2022 Leading Mentor in Cancer Prevention Award, Cancer Prevention Research Training Program
2021	Division of Cancer Prevention Distinguished Paper Award, The University of Texas MD Anderson Cancer Center
2016	Finalists for the Trainee Excellence in Research Poster Award and Finalists for the Staff Excellence in Research Poster Award, 2016 Cancer Survivorship Research Symposium
2016	Best Research Abstract at the Perioperative Cancer Anaesthesia Conference, Royal Marsden NHS Foundation Trust
2015	Poster Finalist, Division of Internal Medicine Research Retreat
2014 - 2022	National Researcher Level 2, CONACyT - Mexican Council for Science and Technology
2013	Best Research Project, Kelsey Seybold Research Foundation
2012	Division of Internal Medicine's Distinguished Paper Award of the Quarter, The University of Texas MD Anderson Cancer Center
2011 - 2013	National Researcher Level 1, CONACyT – Mexican Council for Science and Technology
2011	Department of General Internal Medicine Educator of the Year, University of Texas MD Anderson Cancer Center
2008	Bursary Award, SPondyloArthritis Research & Treatment Network
2008	Bursary Award, American College of Rheumatology
2007	Best Research Project in Clinical Aspects and Treatment, European League Against Rheumatism
2007	Best Research Project in Rheumatology, Mexican College of Rheumatology

Professional Memberships

Society for Research Synthesis Methodology

2022 - Present

Community Participation Action Group

2021 - Present

Cochrane US Network

2020 - Present

Dissemination and Implementation workgroup

2019 - Present

Decision Science Laboratory

2019 - Present

Houston Area Chapter of the American Statistical Association

2015 - 2016

Society of Medical Decision Making

2015 - Present

American Economic Association

2015 - Present

International Society for Pharmacoeconomics and Outcomes Research

2013 - 2015

Health Technology Assessment International - ISG on Information Resources

2013 - 2019

Cochrane Collaborations Comparing Multiple Interventions Methods Group

2012 - Present

Campbell and Cochrane Economics Methods Group

2010 - Present

Spondyloarthritis Research & Treatment Network

2008 - Present

Outcome Measures in Rheumatology

2008 - Present

American College of Rheumatology

2007 - Present

Instituto de Investigaciones Epidemiologicas. Academia Nacional de Medicina

2006 - Present

Cochrane Musculoskeletal Group

2006 - Present

Colegio Medico de Tlaquepaque, Jalisco A.C

2004 - Present

Colegio de Medicos Cirujanos y Parteros del Estado de Jalisco A.C

2003 - Present

Colegio de Toxiologia del Estado de Jalisco, A.C

2001 - Present

Selected Publications

Peer-Reviewed Articles

Laserna A, Laserna A, Cuenca JA, Cuenca JA, Martin P, Martin P, Fowler C, Fowler C, Barahona-Correa J, Barahona-Correa J, Manjappachar N, Manjappachar N, Fowler C, Fowler C, Lopez-Olivo MA, Lopez-Olivo MA, Borges M, Borges M, Sprung CL, Sprung CL, Nates JL, Nates JL. Mortality time frame variability in septic shock clinical trials: A systematic review. Medicina intensiva, 2025. e-Pub 2025.
Tan, NQ, Nargund, R, Douglas, E, Lopez-Olivo, MA, Resong, PJ, Ishizawa, S, Nofal, S, Krause, KJ, Volk, R, Toumazis, I. Acceptability and perceptions of personalised risk-based cancer screening among health-care professionals and the general public. The Lancet Public Health 10(2):e85-e96, 2025. e-Pub 2025. PMID: 39909697.
Lopez-Olivo MA, Kachira JJ, Madramootoo S, Michaud K, Schumacher R, Cinciripini P, Suarez-Almazor ME. Physician views and attitudes regarding tobacco-cessation strategies for patients with rheumatoid arthritis. Arthritis Care Res (Hoboken), 2025. e-Pub 2025. PMID: 39828986.
Bruera S, Bowman S, Huang Y, Suarez-Almazor ME, Lo GH, Lopez-Olivo M, Chiao E, Kramer JR, Pereira FA, Agarwal SK. Factors associated with adherence of cervical cancer screening in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 76(9):1224-1231, 2024. e-Pub 2024. PMID: 38682616.
Lopez-Olivo MA, Kachira JJ, Abdel-Wahab N, Pundole X, Aldrich JD, Carey P, Khan M, Geng Y, Pratt G, Suarez-Almazor ME. A systematic review and meta-analysis of observational studies and uncontrolled trials reporting on the use of checkpoint blockers in patients with cancer and pre-existing autoimmune disease. Eur J Cancer 207:114148, 2024. e-Pub 2024. PMID: 38834015.
Lopez-Olivo MA, James J, James J, Krause KJ, Roth M, Palos GR, Ma H, Rodriguez A, Gilmore K, Cinciripini P, Suarez-Almazor ME. A systematic review and meta-analysis of e-cigarette use among cancer survivors. J Cancer Surviv 18(3):1059-1074, 2024. e-Pub 2023. PMID: 36952212.
Weinbrecht-Mischkewitz, M, Kamal, M, Asim, F, Guillemin, F, Goel, N, Voshaar, M, Boonen, A, Berthelsen, DB, Toupin-April, K, Lopez-Olivo, MA, Sloan, VS, Boers, M, Jones, CA, van der Horst-Bruinsma, IE, Cashin, AG, Sharma, S, Leong, AL, Alten, R, Shea, B, March, LM, Tugwell, P, Christensen, R, Nielsen, SM. Generating a list of potentially important contextual factors covering randomized trials, cohorts, and measurement property studies. Seminars in Arthritis and Rheumatism 65, 2024. e-Pub 2024. PMID: 38290371.
Benavent, D, Carmona, L, Lopez-Olivo, MA, Hill, CL, Westrich-Robertson, T, Goel, N, Strand, V, Shea, B, Grosskleg, S, Leong, AL, Hofstetter, C, Bingham, C, Meyer, D, Constien, D, Berthelsen, DB, Schultz, G, de Groot, I, Weiner, J, Mather, K, De Wit, M, Böhm, P, Cembalo, SM, Tugwell, P, Bruera, S, Suarez-Almazor, M. Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis. Seminars in Arthritis and Rheumatism 64, 2024. e-Pub 2024. PMID: 38118370.
Lopez-Olivo MA, Lin H, Parker S, Barbo Barthel A, Suarez-Almazor ME. Impact of decision-making role preferences on the efficacy of educational tools for patients with common rheumatologic conditions. Rheum Int. e-Pub 2024.
Manzano JG, Sharma S, Lopez-Olivo MA, Suarez-Almazor ME. Association of diabetes treatment with breast cancer outcomes: a systematic review and meta-analysis. Supportive Care in Cancer. e-Pub 2024.
Ruiz JI, Burugu V, Lopez-Olivo MA, Geng Y, Suarez-Almazor ME. Clinical practice guidelines recommendations about cancer screening in patients with autoimmune diseases: a systematic review. e-Pub 2024.
Lopez-Olivo MA, Madramootoo S, Kachira JJ, Michaud K, Schumacher R, Cinciripini P, Suarez-Almazor ME. Preferences regarding tobacco cessation strategies, barriers to success in cessation , and perceived needs of patients with rheumatoid arthritis. Seminars in arthritis and rheumatism. e-Pub 2024.
Corps KN, Terry O, Geng Y, Meara AS, Liew D, Kostine M, Lopez-Olivo MA. The impact of immune-related adverse events in cancer patients: A systematic review with meta-synthesis. Critical reviews in oncology/hematology. e-Pub 2024.
Bowman S, Agarwal SK, Ferguson KC, Maliekel MJ, Lopez-Olivo MA, Suarez-Almazor ME, Danila MI, Yazdany J, Bruera S. Telemedicine for under-resourced patients with systemic lupus erythematosus: A qualitative study exploring the views and experiences of patients and providers. e-Pub 2024.
Ruiz JI, Madramootoo ST, Lopez-Olivo MA, Singh N, Suarez-Almazor ME. Beliefs, Attitudes, and Preferences of Patients with Rheumatoid Arthritis (RA) and Concomitant Cancer with Respect to RA Therapy. Arthritis Rheumatol 75(suppl 9), 2023. e-Pub 2023.
Lopez-Olivo MA, Suarez-Almazor ME, Duhon GF, Erck M, Lu H, Calabrese C, Altan M, Tawbi H, Meara A, Bingham CO, Diab A, Leal VB, Volk RJ. Development and user testing of a website for cancer patients with pre-existing autoimmune disease who are considering immune checkpoint inhibitor therapy. JIMR Cancer 11(Suppl 1), 2023. e-Pub 2023.
Talwar A, Lopez-Olivo MA, Huang Y, Ying L, Aparasu RR. Advanced machine learning algorithms perform better than logistic regression in predicting hospital readmissions: A meta-analysis. Explor Res Clin Soc Pharm 11:100317, 2023. e-Pub 2023. PMID: 37662697.
Lopez-Olivo MA, Kachira JJ, Buni M, Kim ST, Lu H, Tayar JH, Duhon GF, Ruiz JI, Bingham CO 3rd, Calabrese C, Volk RJ, Suarez-Almazor ME. Learning needs of patients with cancer and a pre-existing autoimmune disease who are candidates to receive immune checkpoint inhibitors. Cancers (Basel) 15(15), 2023. e-Pub 2023. PMID: 37568819.
Lopez-Olivo MA, Michaud K, Schumacher R, Minnix J, Cinciripini P, Suarez-Almazor ME. Smoking cessation patterns, usefulness of quitting methods, and tobacco cessation motivators and barriers to quit in patients with rheumatoid arthritis. Clin Rheumatol 42(8):2053-2068, 2023. e-Pub 2023. PMID: 37093403.
Bruera S, Sreedhar A, Agarwal SK, Muthukumar V, Geng Y, Lopez-Olivo MA. Immunosuppression for the treatment of pulmonary hypertension in patients with systemic lupus erythematosus: A systematic review. Int J Rheum Dis 26(6):1022-1028, 2023. e-Pub 2023. PMID: 37140198.
Lowenstein LM, Shih YT, Minnix J, Lopez-Olivo MAA, Maki KG, Kypriotakis G, Leal VB, Shete SS, Fox J, Nishi SP, Cinciripini PM, Volk RJ. A protocol for a cluster randomized trial of care delivery models to improve the quality of smoking cessation and shared decision making for lung cancer screening. Contemp Clin Trials 128:107141, 2023. e-Pub 2023. PMID: 36878389.
Ruiz JI, Lopez-Olivo MA, Geng Y, Suarez-Almazor ME. COVID-19 outcomes in patients with cancer receiving immune checkpoint inhibitors: a systematic review. J Immunother Precis Oncol 6(2):103-110, 2023. e-Pub 2023. PMID: 37214207.
Lopez-Olivo MA, Duhon GF, Ruiz JI, Altan M, Tawbi H, Diab A, Bingham CO, Calabrese C, Heredia NI, Volk RJ, Suarez-Almazor ME. Physician views on the provision of information on immune checkpoint inhibitor therapy to patients with cancer and pre-existing autoimmune disease: a qualitative study. Cancers (Basel) 15(10), 2023. e-Pub 2023. PMID: 37345026.
Negrón JB, Lopez-Olivo MA, Carmona L, Christensen R, Ingegnoli F, Zamora NV, Gamez-Nava JI, Gonzalez-Lopez L, Strand V, Goel N, Westrich-Robertson T, Suarez-Almazor ME. Patient perspectives on long-term outcomes in rheumatoid arthritis. A qualitative study from the OMERACT patient outcomes in longitudinal studies working group. Semin Arthritis Rheum 58:152028, 2023. e-Pub 2023. PMID: 35654619.
Ghosh N, Couette N, van Binsbergen WH, Weinmann SC, Jivanelli B, Shea B, Bass AR, Benesova K, Bingham CO, Calabrese C, Cappelli LC, Chan KK, Choy E, Daoussis D, Goodman S, Hudson M, Jamal S, Leipe J, Lopez-Olivo MA, Suarez-Almazor M, van der Laken CJ, Meara AS, Liew D, Kostine M. Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: a scoping review by the OMERACT irAE working group. Semin Arthritis Rheum 58:152110, 2023. e-Pub 2023. PMID: 36372016.
Ruiz JI, Lopez-Olivo MA, Geng Y, Suarez-Almazor ME. COVID-19 vaccination in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysis. J Immunother Cancer 11(2), 2023. e-Pub 2023. PMID: 36746512.
Reid, PD, Sandigursky, S, Song, J, Lopez-Olivo MA, Safa, H, Cytryn, S, Efuni, E, Buni, M, Pavlick, AC, Krogsgaard, M, Abu-Shawer, O, Altan, M, Weber, JS, Rahma, OE, Suarez-Almazor, M, Diab, A, Hassan, NA. Safety, and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases. OncoImmunology 12(1), 2023. e-Pub 2023. PMID: 38126033.
Tan NQP, Maki KG, Lopez-Olivo MA, Geng Y, Volk RJ. Cultural influences on shared decision-making among Asian Americans: A systematic review and meta-synthesis of qualitative studies. Patient Educ Couns S0738-3991(22):00823-0, 2023. e-Pub 2023. PMID: 36344320.
Lopez-Olivo, MA, Sharma, G, Singh, G, James, J, Krause, KJ, Cinciripini, PM, Volk, R, Suarez-Almazor, M. A systematic review with meta-analysis of the effects of smoking cessation strategies in patients with rheumatoid arthritis. PloS one 17(12 December), 2022. e-Pub 2022. PMID: 36520847.
Bruera S, Ventura MJ, Agarwal SK, Krause KJ, Lopez-Olivo MA. The utility of erythrocyte sedimentation rate, C-reactive protein, and procalcitonin in detecting infections in patients with systemic lupus erythematosus: A systematic review. Lupus 31(10):9612033221106157, 2022. e-Pub 2022. PMID: 35650026.
Nazer L, Lopez-Olivo MA, Brown AR, Cuenca J, Sirimaturos M, Khader H, Alqadheeb N, May H, Milano V, Taylor A, Nates J. A systematic review and meta-analysis evaluating geographical variation in outcomes of cancer patients treated in intensive care units. Crit Care Explor 4(9):0757, 2022. e-Pub 2022. PMID: 36119395.
Shen C, Tannenbaum D, Horn R, Rogers J, Eng C, Johnson B, Kopetz S, Morris V, Overman M, Parseghian C, Chang G, Lopez -Olivo MA, Kanwal R, Dasari A. Shifting patterns in the design and outcomes of phase III clinical trials in advanced colorectal cancer. JAMA Netw Open 5(5):e2213588, 2022. e-Pub 2022. PMID: 35608860.
Frade, S, Cameron, M, Espinosa-Cuervo, G, Suarez-Almazor, M, Lopez-Olivo, MA. Exercise and physical therapy for systemic sclerosis. Cochrane Database of Systematic Reviews 2022(3), 2022. e-Pub 2022.
Yadav, D, Hwang, H, Qiao, W, Upadhyay, R, Chapin, BF, Tang, C, Aparicio, A, Lopez-Olivo, MA, Kang, SK, Macapinlac, HA, Bathala, TK, Surasi, DS. 18F-fluciclovine versus PSMA PET imaging in primary tumor detection during initial staging of high-risk prostate cancer. Radiology: Imaging Cancer 4(2), 2022. e-Pub 2022. PMID: 35212559.
Tan NQP, Nishi SPE, Lowenstein LM, Mendoza TR, Lopez-Olivo MA, Crocker LC, Sepucha KR, Volk RJ. Impact of the shared decision-making process on lung cancer screening decisions. Cancer Med 11(3):790-797, 2022. e-Pub 2022. PMID: 34964284.
Lopez -Olivo MA, des Bordes JKA, Jibaja-Weiss M, Volk RJ, Suarez-Almazor ME. Preferred strategies for delivering health information to patients with musculoskeletal disorders: a qualitative study. J Clin Rheumatol 28(1):e102-e109, 2022. e-Pub 2022. PMID: 33298811.
Bruera S, Lopez-Olivo MA, Siddhanamatha HR, Molony DA, Mayes MD, Suarez-Almazor ME. Stem cell transplantation for systemic sclerosis. Cochrane Database Syst Rev 7(7):CD011819, 2022. e-Pub 2022. PMID: 35904231.
Lowenstein LM, Nishi SPE, Lopez-Olivo MA, Crocker LC, Choi N, Kim B, Shih YT, Volk RJ. Smoking cessation services and shared decision-making practices among lung cancer screening facilities: a cross-sectional study. Cancer 128(10):1967-1975, 2022. e-Pub 2022. PMID: 35157302.
Bommareddy K, Hamade H, Lopez-Olivo MA, Wehner M, Tosh T, Barbieri JS. Association of spironolactone use with risk of cancer: a systematic review and meta-analysis. JAMA Dermatol 158(3):275-282, 2022. e-Pub 2022. PMID: 35138351.
Suarez-Almazor ME, Pundole X, Cabanillas G, Lei X, Zhao H, Elting LS, Lopez-Olivo MA, Giordano SH. Association of bone mineral density testing with risk of major osteoporotic fractures among older men receiving androgen deprivation therapy to treat localized or regional prostate cancer. JAMA Netw Open 5(4):e225432, 2022. e-Pub 2022. PMID: 35363269.
Lopez-Olivo MA, Foreman JT, Leung C, Lin HY, Westrich-Robertson T, Hofstetter C, des Bordes JKA, Lyddiatt A, Leong A, Willcockson IU, Peterson SK, Suarez-Almazor ME. A randomized controlled trial evaluating the effects of social networking on chronic disease management in rheumatoid arthritis. Semin Arthritis Rheum 56:152072, 2022. e-Pub 2022. PMID: 35872394.
Lopez-Olivo MA, Valerio V, Karpes Matusevich AR, Brizio M, Kwok M, Geng Y, Suarez-Almazor ME, Colmegna I. Safety and efficacy of influenza vaccination in patients receiving immune checkpoint inhibitors. Systematic review with meta-analysis. Vaccines (Basel) 10(8):1195, 2022. e-Pub 2022. PMID: 36016085.
Ruiz JI, Singh G, Erck M, Geng Y, Suarez-Almazor ME, Lopez-Olivo MA. Quality and content evaluation of websites with information about immune checkpoint inhibitors: an environmental scan. PLoS One 17(10):e0275676, 2022. e-Pub 2022. PMID: 36215234.
Nazer L, Lopez-Olivo MA, Brown AR, Cuenca J, Sirimaturos M, Khader H, Alqadheeb N, May H, Milano V, Taylor A, Nates J. Support Care Cancer. All-cause mortality in cancer patients treated for sepsis in intensive care units: a systematic review and meta-analysis 1(11):10099-10109, 2022. e-Pub 2022. PMID: 36214879.
Mama SK, Lopez-Olivo MA, Bhuiyan N, Leach HJ. Effectiveness of physical activity interventions among rural cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 30(12):2143-2153, 2021. e-Pub 2021. PMID: 34620628.
Karpes Matusevich AR, Duan Z, Zhao H, Lal LS, Chan W, Suarez-Almazor ME, Giordano SH, Swint JM, Lopez -Olivo MA. Treatment sequences after discontinuing a tumor necrosis factor inhibitor in patients with rheumatoid arthritis. A comparison of cycling versus swapping strategies. Arthritis Care Res (Hoboken) 73(10):1461-1469, 2021. e-Pub 2021. PMID: 32558339.
Lopez -Olivo MA, Lin H, Rizvi T, Barbo Barthel A, Ingleshwar A, des Bordes JKA, Jibaja-Weiss M, Volk RJ, Suarez-Almazor ME. Randomized controlled trial of patient education tools for patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 73(10):1470-1478, 2021. e-Pub 2021. PMID: 32583971.
Bruera S, Carmona L, Lopez-Olivo MA, Westrich-Robertson T, March L, Negron JB, Christensen R, Strand V, Ingegnoli F, Goel N, Shea B, Tugwell P, Leong A, Bingham CO, Hill CL, Suarez-Almazor ME. Development of a patient-centered core domain set for prospective observational longitudinal outcome studies in rheumatoid arthritis: an OMERACT initiative. Semin Arthritis Rheum 51(5):1113-1116, 2021. e-Pub 2021. PMID: 34446270.
Makhnoon S, Bednar EM, Krause KJ, Peterson SK, Lopez-Olivo MA. Clinical management among individuals with variant of uncertain significance in hereditary cancer: A systematic review and meta-analysis. Clin Genet 100(2):119-131, 2021. e-Pub 2021. PMID: 33843052.
Nishi SPE, Lowenstein LM, Mendoza TR, Lopez -Olivo MA, Crocker LC, Sepucha K, Niu J, Volk RJ. Shared decision-making for lung cancer screening: how well are we "sharing"?. Chest 160(1):330-340, 2021. e-Pub 2021. PMID: 33556362.
Maki KG, Liao K, Lowenstein LM, Lopez -Olivo MA, Volk RJ. Factors associated with obtaining lung cancer screening among persons who smoke. MDM Policy Pract 6(2):23814683211067810, 2021. e-Pub 2021. PMID: 34993342.
Lopez -Olivo MA, Zogala RJ, des Bordes J, Zamora NV, Christensen R, Rai D, Goel N, Carmona L, Pratt G, Strand V, Suarez-Almazor ME. Outcomes reported in prospective long-term observational studies and registries of patients with rheumatoid arthritis worldwide: an OMERACT systematic review. Arthritis Care Res (Hoboken) 73(5):649-657, 2021. e-Pub 2021. PMID: 32004421.
Lopez -Olivo MA, des Bordes JK, Lin H, Volk RJ, Rizvi T, Suarez-Almazor ME. A randomized controlled trial comparing two self-administered educational strategies for patients with knee osteoarthritis. ACR Open Rheumatol 3(3):185-195, 2021. e-Pub 2021. PMID: 33590950.
Lopez -Olivo MA, Minnix JA, Fox JG, Nishi SPE, Lowenstein LM, Maki KG, Leal VB, Tina Shih YC, Cinciripini PM, Volk RJ. Smoking cessation and shared decision-making practices about lung cancer screening among primary care providers. Cancer Med 10(4):1357-1365, 2021. e-Pub 2021. PMID: 33463091.
Lopez-Olivo MA, des Bordes JKA, Syed MN, Alemam A, Dodeja A, Abdel-Wahab N, Suarez-Almazor ME. Quality appraisal of educational websites about osteoporosis and bone health. Arch Osteoporos 16(1):28, 2021. e-Pub 2021. PMID: 33566216.
Karpes Matusevich AR, Lai LS, Chan W, Swint JM, Cantor SB, Suarez-Almazor ME, Lopez -Olivo MA. Cost-utility analysis of treatment options after initial tumor necrosis factor inhibitor therapy discontinuation in patients with rheumatoid arthritis. J Manag Care Spec Pharm 27(1):73-83, 2021. e-Pub 2021. PMID: 33377443.
Yadav D, Hwang H, Qiao W, Wang X, Chapin B, Tang C, Aparicio A, Lopez -Olivo MA, Kang S, Macapinlac H, Tharakeswara B, Shilpa Surasi D. 18F-fluciclovine versus PSMA PET imaging in the initial staging of primary tumor in high-risk prostate cancer: a systematic review and meta-analysis. Radiology: Imaging Cancer, 2021. e-Pub 2021.
Lopez-Olivo MA, Maki KG, Choi NJ, Hoffman RM, Shih YT, Lowenstein LM, Hicklen RS, Volk RJ. Patient adherence to screening for lung cancer in the US: a systematic review and meta-analysis. JAMA Netw Open 3(11):e2025102, 2020. e-Pub 2020. PMID: 33196807.
Lopez -Olivo MA, Ingleshwar A, Landon GC, Siff SJ, Barbo A, Lin HY, Suarez-Almazor ME. Psychosocial determinants of total knee arthroplasty outcomes two years after surgery. ACR Open Rheumatol 2(10):573-581, 2020. e-Pub 2020. PMID: 32969193.
Laserna A, Durán-Crane A, Lopez-Olivo MA, Cuenca JA, Fowler C, Díaz DP, Cardenas YR, Urso C, O'Connell K, Fowler C, Price KJ, Sprung CL, Nates JL. Pain management during the withholding and withdrawal of life support in critically ill patients at the end-of-life: a systematic review and meta-analysis. Intensive Care Med 46(9):1671-1682, 2020. e-Pub 2020. PMID: 32833041.
Paramasivan A, Lopez-Olivo MA, Foong TW, Tan YW, Yap APA. Intrathecal dexmedetomidine and postoperative pain: A systematic review and meta-analysis of randomized controlled trials. Eur J Pain 24(7):1215-1227, 2020. e-Pub 2020. PMID: 32333825.
des Bordes JKA, Foreman J, Westrich-Robertson T, Lopez -Olivo MA, Peterson SK, Hofstetter C, Lyddiatt A, Willcockson I, Leong A, Suarez-Almazor ME. Interactions, and perceptions of patients with rheumatoid arthritis participating in an online support group. Clin Rheumatol 39(6):1775-1782, 2020. e-Pub 2020. PMID: 32006180.
Lopez -Olivo MA, des Bordes JKA, Lin H, Rizvi T, Volk RJ, Suarez-Almazor ME. Comparison of multimedia and printed patient education tools for patients with osteoporosis: a 6-month randomized controlled trial. Osteoporos Int 31(5):857-866, 2020. e-Pub 2020. PMID: 31844906.
Abdel-Wahab N, Tayar JH, Fa'ak F, Sharma G, Lopez -Olivo MA, Yousif A, Shagroni T, Al-Hawamdeh S, Rojas-Hernandez CM, Suarez-Almazor ME. Systematic review of observational studies reporting antiphospholipid antibodies in patients with solid tumors. Blood Adv 4(8):1746-1755, 2020. e-Pub 2020. PMID: 32337583.
Karpes Matusevich AR, Suarez-Almazor ME, Cantor SB, Lal LS, Swint JM, Lopez -Olivo MA. Systematic review of economic evaluations of cycling versus swapping in patients with rheumatoid arthritis after failure to tumor necrosis factor inhibitors. Arthritis Care Res (Hoboken) 72(3):343-352, 2020. e-Pub 2020. PMID: 30801951.
Lopez-Olivo MA, Colmegna I, Karpes Matusevich AR, Qi SR, Zamora NV, Sharma R, Pratt G, Suarez-Almazor ME. Systematic review of recommendations on the use of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and cancer. Arthritis Care Res (Hoboken) 72(3):309-318, 2020. e-Pub 2020. PMID: 30821928.
des Bordes J, Prasad S, Pratt G, Suarez-Almazor ME, Lopez-Olivo MA. Knowledge, beliefs, and concerns about bone health from a systematic review and metasynthesis of qualitative studies. PLoS One 15(1):e0227765, 2020. e-Pub 2020. PMID: 31940409.
Durán-Crane A, Laserna A, Lopez -Olivo MA, Cuenca JA, Díaz DP, Cardenas YR, Urso C, O'Connell K, Azimpoor K, Fowler C, Price KJ, Sprung CL, Nates JL. Clinical practice guidelines and consensus statements about pain management in critically Ill end-of-life patients: a systematic review. Crit Care Med 47(11):1619-1626, 2019. e-Pub 2019. PMID: 31517694.
Smith GL, Lopez -Olivo MA, Advani PG, Ning MS, Geng Y, Giordano SH, Volk RJ. Financial burdens of cancer treatment: a systematic review of risk factors and outcomes. J Natl Compr Canc Netw 17(10):1184-1192, 2019. e-Pub 2019. PMID: 31590147.
Lopez -Olivo MA, Negrón JB, Zogala RJ, Carmona L, Criner K, Goel N, Gonzalez-Lopez L, Ingegnoli F, Leong A, March L, Shea B, Strand V, Tugwell P, Westrich-Robertson T, Zamora NV, Christensen R, Suarez-Almazor ME. Core outcome sets specifically for long-term observational studies: OMERACT special interest group update in rheumatoid arthritis. J Rheumatol 46(9):1164-1167, 2019. e-Pub 2019. PMID: 30824644.
Yap A, Lopez -Olivo MA, Dubowitz J, Hiller J, Riedel B, Collaboration Group GOR. Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia. Can J Anaesth 66(5):546-561, 2019. e-Pub 2019. PMID: 30834506.
Abdel-Wahab N, Rai D, Siddhanamatha H, Dodeja A, Suarez-Almazor ME, Lopez -Olivo MA. A comprehensive scoping review to identify standards for the development of health information resources on the internet. PLoS One 14(6):e0218342, 2019. e-Pub 2019. PMID: 31220126.
Lopez-Olivo MA, Kakpovbia-Eshareturi V, des Bordes JK, Barbo A, Christensen R, Suarez-Almazor ME. Treating early undifferentiated arthritis: a systematic review and meta-analysis of direct and indirect trial evidence. Arthritis Care Res (Hoboken) 70(9):1355-1365, 2018. e-Pub 2018. PMID: 29161466.
des Bordes JKA, Gonzalez E, Lopez -Olivo MA, Shethia M, Nayak P, Suarez-Almazor ME. Assessing information needs and use of online resources for disease self-management in patients with rheumatoid arthritis: a qualitative study. Clin Rheumatol 37(7):1791-1797, 2018. e-Pub 2018. PMID: 29500557.
Yap A, Lopez-Olivo MA, Dubowitz J, Pratt G, Hiller J, Gottumukkala V, Sloan E, Riedel B, Schier R. Effect of beta-blockers on cancer recurrence and survival: a meta-analysis of epidemiological and perioperative studies. Br J Anaesth 121(1):45-57, 2018. e-Pub 2018. PMID: 29935594.
Abdel-Wahab N, Talathi S, Lopez-Olivo MA, Suarez-Almazor ME. Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis. Lupus 27(4):572-583, 2018. e-Pub 2018. PMID: 28945149.
Lopez-Olivo MA, Ingleshwar A, Volk RJ, Jibaja-Weiss M, Barbo A, Saag K, Leong A, Suarez-Almazor ME. Development and pilot testing of multimedia patient education tools for patients with knee osteoarthritis, osteoporosis, and rheumatoid arthritis. Arthritis Care Res (Hoboken) 70(2):213-220, 2018. e-Pub 2018. PMID: 28464546.
Abdel-Wahab N, Shah M, Lopez-Olivo MA, Suarez-Almazor ME. Use of immune checkpoint inhibitors in the treatment of patients with cancer and preexisting autoimmune disease: a systematic review. Ann Intern Med 168(2):121-130, 2018. e-Pub 2018. PMID: 29297009.
Zamora NV, Christensen R, Goel N, Klokker L, Lopez -Olivo MA, Kristensen LE, Carmona L, Strand V, Curtis JR, Suarez-Almazor ME. Critical outcomes in longitudinal observational studies, and registries in patients with rheumatoid arthritis: an OMERACT special interest group report. J Rheumatol 44(12):1894-1898, 2017. e-Pub 2017. PMID: 28620065.
He T, Lopez-Olivo MA, Hur C, Chhatwal J. Systematic review: cost-effectiveness of direct-acting antivirals for treatment of hepatitis C genotypes 2-6. Aliment Pharmacol Ther 46(8):711-721, 2017. e-Pub 2017. PMID: 28836278.
Des Bordes JKA, Suarez-Almazor ME, Volk RJ, Lu H, Edwards B, Lopez -Olivo MA. Online educational tool to promote bone health in cancer survivors. J Health Commun 22(10):808-817, 2017. e-Pub 2017. PMID: 28922062.
Chhatwal J, He T, Hur C, Lopez-Olivo MA. Direct-acting antiviral agents for patients with hepatitis C virus genotype 1 infection are cost-saving. Clin Gastroenterol Hepatol 15(6):827-837.e8, 2017. e-Pub 2017. PMID: 27650326.
Siddhanamatha HR, Heung E, Lopez-Olivo MA, Abdel-Wahab N, Ojeda-Prias A, Willcockson I, Leong A, Suarez-Almazor ME. Quality assessment of websites providing educational content for patients with rheumatoid arthritis. Semin Arthritis Rheum 46(6):715-723, 2017. e-Pub 2017. PMID: 28258768.
Pundole X, Cheema HI, Petitto GS, Lopez-Olivo MA, Suarez-Almazor ME, Lu H. Prevention and treatment of bone loss and fractures in patients undergoing a hematopoietic stem cell transplant: a systematic review and meta-analysis. Bone Marrow Transplant 52(5):663-670, 2017. e-Pub 2017. PMID: 28112742.
Pan X, Lopez-Olivo MA, Song J, Pratt G, Suarez-Almazor ME. Systematic review of the methodological quality of controlled trials evaluating Chinese herbal medicine in patients with rheumatoid arthritis. BMJ Open 7(3):e013242, 2017. e-Pub 2017. PMID: 28249848.
Singh JA, Hossain A, Tanjong Ghogomu E, Mudano AS, Maxwell LJ, Buchbinder R, Lopez-Olivo MA, Suarez-Almazor ME, Tugwell P, Wells GA. Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis. Cochrane Database Syst Rev 3(3):CD012591, 2017. e-Pub 2017. PMID: 28282491.
Abdel-Wahab N, Lopez-Olivo MA, Pinto-Patarroyo GP, Suarez-Almazor ME. Systematic review of case reports of antiphospholipid syndrome following infection. Lupus 25(14):1520-1531, 2016. e-Pub 2016. PMID: 27060064.
Bruera S, Barbo AG, Lopez-Olivo MA. Use of medication reminders in patients with rheumatoid arthritis. Rheumatol Int 36(11):1543-1548, 2016. e-Pub 2016. PMID: 27590013.
Volk RJ, Linder SK, Lopez-Olivo MA, Kamath GR, Reuland DS, Saraykar SS, Leal VB, Pignone MP. Patient decision aids for colorectal cancer screening: a systematic review and meta-analysis. Am J Prev Med 51(5):779-791, 2016. e-Pub 2016. PMID: 27593418.
Waimann CA, Fernandez-Mazarambroz RJ, Cantor SB, Lopez-Olivo MA, Barbo AG, Landon GC, Siff SJ, Lin H, Suarez-Almazor ME. Effect of body mass index and psychosocial traits on total knee replacement costs in patients with osteoarthritis. J Rheumatol 43(8):1600-6, 2016. e-Pub 2016. PMID: 27307528.
des Bordes JK, Abdel-Wahab N, Suarez-Almazor M, Lopez-Olivo MA. Assessing information needs on bone health in cancer survivors. J Cancer Surviv 10(3):480-8, 2016. e-Pub 2016. PMID: 26499252.
Prescott LS, Taylor JS, Lopez-Olivo MA, Munsell MF, VonVille HM, Lairson DR, Bodurka DC. How low should we go: A systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology. Cancer Treat Rev 46:1-8, 2016. e-Pub 2016. PMID: 27046422.
Lopez-Olivo MA, Amezaga Urruela M, McGahan L, Pollono EN, Suarez-Almazor ME. Rituximab for rheumatoid arthritis. Cochrane Database Syst Rev 1(1):CD007356, 2015. e-Pub 2015. PMID: 25603545.
Lopez-Olivo MA, Siddhanamatha HR, Shea B, Tugwell P, Wells GA, Suarez-Almazor ME. Methotrexate for treating rheumatoid arthritis. Cochrane Database Syst Rev 2014(6):CD000957, 2014. e-Pub 2014. PMID: 24916606.
Waimann CA, Fernandez-Mazarambroz RJ, Cantor SB, Lopez-Olivo MA, Zhang H, Landon GC, Siff SJ, Suarez-Almazor ME. Cost-effectiveness of total knee replacement: a prospective cohort study. Arthritis Care Res (Hoboken) 66(4):592-9, 2014. e-Pub 2014. PMID: 24124052.
de Achaval S, Kallen MA, Mayes MD, Lopez-Olivo MA, Suarez-Almazor ME. Use of the patient-generated index in systemic sclerosis to assess patient-centered outcomes. J Rheumatol 40(8):1337-43, 2013. e-Pub 2013. PMID: 23772081.
Lethaby A, Lopez-Olivo MA, Maxwell L, Burls A, Tugwell P, Wells GA. Etanercept for the treatment of rheumatoid arthritis. Cochrane Database Syst Rev 2013(5):CD004525, 2013. e-Pub 2013. PMID: 23728649.
Peddi P, Lopez-Olivo MA, Pratt GF, Suarez-Almazor ME. Denosumab in patients with cancer and skeletal metastases. Cancer Treat Rev 39(1):97-104, 2013. e-Pub 2013. PMID: 22898302.
Lopez-Olivo MA, Pratt G, Palla S, Salahudeen A. Rasburicase in tumor lysis syndrome of the adult: a systematic review and meta-analysis. Am J Kidney Dis 62(3):481-92, 2013. e-Pub 2013. PMID: 23684124.
Lopez-Olivo MA, Shah NA, Pratt G, Risser JM, Symanski E, Suarez-Almazor ME. Bisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysis. Support Care Cancer 20(11):2985-98, 2012. e-Pub 2012. PMID: 22956190.
Tayar JH, Lopez-Olivo MA, Suarez-Almazor ME. Febuxostat for treating chronic gout. Cochrane Database Syst Rev 11:CD008653, 2012. e-Pub 2012. PMID: 23152264.
Lopez-Olivo MA, Tayar JH, Martinez-López JA, Pollono EN, Cueto JP, Gonzales-Crespo MR, Fulton S, Suarez-Almazor ME. Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis. JAMA 308(9):898-908, 2012. e-Pub 2012. PMID: 22948700.
Lopez-Olivo MA, Andrabi TR, Palla SL, Suarez-Almazor ME. Cervical spine radiographs in patients with rheumatoid arthritis undergoing anesthesia. J Clin Rheumatol 18(2):61-6, 2012. e-Pub 2012. PMID: 22334269.
Lopez-Olivo MA, Landon GC, Siff SJ, Edelstein D, Pak C, Kallen MA, Stanley M, Zhang H, Robinson KC, Suarez-Almazor ME. Psychosocial determinants of outcomes in knee replacement. Ann Rheum Dis 70(10):1775-81, 2011. e-Pub 2011. PMID: 21791452.
Singh JA, Beg S, Lopez-Olivo MA. Tocilizumab for rheumatoid arthritis: a Cochrane systematic review. J Rheumatol 38(1):10-20, 2011. e-Pub 2011. PMID: 20952462.
Pollono EN, Lopez-Olivo MA, Lopez JA, Suarez-Almazor ME. A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis. Clin Rheumatol 29(9):947-55, 2010. e-Pub 2010. PMID: 20383550.
Singh JA, Beg S, Lopez-Olivo MA. Tocilizumab for rheumatoid arthritis. Cochrane Database Syst Rev 7(7):CD008331, 2010. e-Pub 2010. PMID: 20614469.
Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, Ghogomu ET, Tugwell P. Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Sao Paulo Med J 128(5):309-10, 2010. e-Pub 2010. PMID: 21181074.
Singh, JA, Christensen, R, Wells, GA, Suarez-Almazor, M, Buchbinder, R, Lopez-Olivo, MA, Ghogomu, ET, Tugwell, P. A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis. CMAJ 181(11):787-796, 2009. e-Pub 2009. PMID: 19884297.
Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, Tanjong Ghogomu E, Tugwell P. Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Cochrane Database Syst Rev 2013(4):CD007848, 2009. e-Pub 2009. PMID: 19821440.
Maillefert JF, Kloppenburg M, Fernandes L, Punzi L, Günther KP, Martin Mola E, Lohmander LS, Pavelka K, Lopez-Olivo MA, Dougados M, Hawker GA. Multi-language translation and cross-cultural adaptation of the OARSI/OMERACT measure of intermittent and constant osteoarthritis pain (ICOAP). Osteoarthritis Cartilage 17(10):1293-6, 2009. e-Pub 2009. PMID: 19410033.
Aguilar-Chavez EA, Gamez-Nava JI, Lopez-Olivo MA, Galvan-Melendres S, Corona-Sanchez EG, Loaiza-Cardenas CA, Celis A, Cardona-Muñoz EG, Gonzalez-Lopez L. Circulating leptin and bone mineral density in rheumatoid arthritis. J Rheumatol 36(3):512-6, 2009. e-Pub 2009. PMID: 19208597.
Roundtree AK, Kallen MA, Lopez-Olivo MA, Kimmel B, Skidmore B, Ortiz Z, Cox V, Suarez-Almazor ME. Poor reporting of search strategy and conflict of interest in over 250 narrative and systematic reviews of two biologic agents in arthritis: a systematic review. J Clin Epidemiol 62(2):128-37, 2009. e-Pub 2009. PMID: 19013763.
Corona-Sanchez EG, Gonzalez-López L, Muñoz-Valle JF, Vazquez-Del Mercado M, Lopez-Olivo MA, Aguilar-Chavez EA, Salazar-Paramo M, Loaiza-Cardenas C, Oregon-Romero E, Navarro-Hernandez RE, Gamez-Nava JI. Circulating e-selectin and tumor necrosis factor-alpha in extraarticular involvement and joint disease activity in rheumatoid arthritis. Rheumatol Int 29(3):281-6, 2009. e-Pub 2009. PMID: 18726101.
Lopez-Olivo MA, Kallen MA, Ortiz Z, Skidmore B, Suarez-Almazor ME. Quality appraisal of clinical practice guidelines and consensus statements on the use of biologic agents in rheumatoid arthritis: a systematic review. Arthritis Rheum 59(11):1625-38, 2008. e-Pub 2008. PMID: 18975351.
Gonzalez-López L, Sanchez-Hernandez JD, Aguilar-Chavez EA, Cota-Sanchez AR, Lopez-Olivo MA, Villa-Manzano AI, Ortega-Flores R, Espinoza-Magaña GL, Rojo-Contreras W, Cardona-Muñoz EG, Gamez-Nava JI. Hyperhomocysteinemia in ankylosing spondylitis: prevalence and association with clinical variables. Rheumatol Int 28(12):1223-8, 2008. e-Pub 2008. PMID: 18719918.
Gossec L, Jordan JM, Mazzuca SA, Lam MA, Suarez-Almazor ME, Renner JB, Lopez-Olivo MA, Hawker G, Dougados M, Maillefert JF, in OA" OTF"ARAOM. Comparative evaluation of three semi-quantitative radiographic grading techniques for knee osteoarthritis in terms of validity and reproducibility in 1759 X-rays: report of the OARSI-OMERACT task force. Osteoarthritis Cartilage 16(7):742-8, 2008. e-Pub 2008. PMID: 18417373.
Lopez-Olivo MA, Suarez-Almazor ME. Developing guidelines in musculoskeletal disorders. Clin Exp Rheumatol 25(6 Suppl 47):28-36, 2007. e-Pub 2007. PMID: 18021504.
Villa-Manzano AI, Gamez-Nava JI, Salazar-Paramo M, Valera-Gonzalez IC, Garcia-Gonzalez A, Garcia-Gonzalez G, Morales-Romero J, Lopez-Olivo MA, Galvan-Ramirez LM, Ruiz-Ruvalcaba R, Cardona-Muñoz EG, Gonzalez-Lopez L. Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythematosus. Rheumatol Int 26(8):712-6, 2006. e-Pub 2006. PMID: 16231121.
Lopez-Olivo MA, Gonzalez-López L, Garcia-Gonzalez A, Villa-Manzano AI, Cota-Sanchez AR, Salazar-Paramo M, Varon-Villalpando E, Cardona-Muñoz EG, Gamez-Nava JI. Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis. Scand J Rheumatol 35(2):112-6, 2006. e-Pub 2006. PMID: 16641044.
Morales-Romero J, Cázares-Méndez JM, Gámez-Nava JI, Triano-Páez M, Villa-Manzano AI, Lopez-Olivo MA, Rodríguez-Arreola BE, González-López L. Patterns of health care in an outpatient rheumatologic clinic. Reumatol Clin 1(2):87-94, 2005. e-Pub 2005. PMID: 21794243.

Manuals, Teaching Aids, Other Teaching Publications

. Immune checkpoint inhibitors treatment for patients with cancer and autoimmune disease. National Cancer Institute and Rheumatology Research Foundation, 2023.
. Rheumatoid Arthritis. Rheumatology Research Foundation, 2017.
. Bone health in cancer patients and survivors. Duncan Family Institute and the Cancer Center Support Grant, 2014.
. Osteoarthritis of the Knee: a guide for adults | DVD English and Spanish. The Agency for Healthcare Research and Quality (AHRQ), 2013.
. Osteoporosis: treatments that help prevent broken bones a guide for women after menopause | DVD English and Spanish. The Agency for Healthcare Research and Quality (AHRQ), 2013.
. Rheumatoid arthritis: choosing the right medicine | DVD English and Spanish. The Agency for Healthcare Research and Quality (AHRQ), 2013.
. Healthy bones: a decision aid for women with osteoporosis. The Agency for Healthcare Research and Quality (AHRQ), 2012.

Abstracts

Volk RJ, Lowenstein LM, Minnix JA, Lopez-Olivo MA, Lettieri J, Witmer L, Leal VB, Cinciripini PM. Using tobacco counselors to conduct shared decision-making for lung cancer screening with patients who smoke: a cluster randomized trial, 2024. e-Pub 2024.
Goorkiz P, Chan K, Frade S, Cameron M, Martens D, Lopez-Olivo MA. Exercise and physical therapy for systemic sclerosis: ongoing Cochrane systematic review and meta-analysis, 2024. e-Pub 2024.
Bruera S, Bowman S, Ferguson K, Maliekel M, Lopez-Olivo MA, Suarez-Almazor ME, Danila MI, Yazdany J, Agarwal SK. Telemedicine in under-resourced patients with systemic lupus erythematosus: a qualitative study exploring the views and experiences of patients and providers, 2024. e-Pub 2024.
Darnell H, Suarez-Almazor ME, Roth M, Palos GR, Ma HYH, Minnix J, Karam-Hage M, Cinciripini P, Lopez-Olivo MA. Patterns of e-cigarette use and attitudes among cancer survivors, 2024. e-Pub 2024.
Bruera S, Bowman S, Huang Y, Suarez-Almazor M, Lo G, Chiao E, Lopez-Olivo MA, Agarwal S. Factors associated with adherence to cervical cancer screening in ethnically diverse women with systemic lupus erythematosus, 2023. e-Pub 2023.
Ruiz J, Madramootoo S, Lopez-Olivo MA, Singh N, Suarez-Almazor M. Beliefs, attitudes, and preferences of patients with rheumatoid arthritis (RA) and concomitant cancer with respect to RA therapy, 2023. e-Pub 2023.
Bruera S, Huang Y, Bowman S, Suarez-Almazor M, Lo G, Lopez-Olivo MA, Agarwal S. Human papillomavirus vaccine uptakes in ethnically diverse women living with systemic lupus erythematosus. Arthritis Rheumatol, 2023. e-Pub 2023.
Lopez-Olivo MA, Suarez-Almazor ME, Duhon GF, Erck M, Calabrese C, Altan M, Tawbi H, Meara A, Bingham C, Diab A, Leal VB, Volk RJ. Development and user testing of a website with Information for cancer patients who have pre-existing autoimmune disease and are considering immune checkpoint inhibiotrs (ICIs), 2023. e-Pub 2023.
Astorino J, Hirko KA, Adegbovega A, Lopez-Olivo MA, Chichester L, Nataliansyah M, Nock N, Christy S, Levett P, Ginex P. Utilizing champions to enhance implementation of clinical and community-based interventions in cancer: A scoping review. Poster Session: Building the Future of D&I Science: Capacity Building, Infrastructure, and Emerging Research Areas, 2023. e-Pub 2023.
Lopez-Olivo MA, Suarez-Almazor ME, Duhon GF, Erck M, Calabrese C, Altan M, Tawbi H, Meara A, Bingham C, Diab A, Leal VB, Volk RJ. Development and user testing of a website with Information for cancer patients who have pre-existing autoimmune disease and are considering immune checkpoint inhibiotrs (ICIs), 2023. e-Pub 2023.
Lopez-Olivo MA, Sharma G, Qureshi S, Hicklen RS, Tayar JH, Suarez-Almazor ME. A systematic review with meta-analysis of radiotherapy adverse events in patients with cancer and lupus erythematosus, 2023. e-Pub 2023.
Lopez-Olivo MA, Suarez-Almazor ME, Duhon GF, Erck M, Calabrese C, Altan M, Tawbi H, Meara A, Bingham C, Diab A, Leal VB, Volk RJ. Development and user testing of a website with Information for cancer patients who have pre-existing autoimmune disease and are considering immune checkpoint inhibiotrs (ICIs), 2023. e-Pub 2023.
Lopez-Olivo MA, Sharma G, Qureshi S, Hicklen RS, Tayar JH, Suarez-Almazor ME. Adverse events with the use of radiotherapy in patients with inflammatory arthritides and cancer: A systematic review and meta-analysis, 2023. e-Pub 2023.
Ghosh N, Couette N, van Binsbergen W, Weinmann S, Jivanelli B, Shea B, Bass A, Benesova K, Bingham III C, Calabrese C, C Cappelli L, Chan K, Choy E, Daoussis D, Goodman S, Hudson M, Jamal S, Leipe J, Lopez-Olivo MA, Suarez-Almazor M, van der Laken C, Meara A, Liew D, Kostine M. Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: a scoping review by the OMERACT IrAE working group 74(9), 2022. e-Pub 2022.
Nazer L, Lopez-Olivo MA, Cuenca JA, Awad W, Brown AR, Abusara A, Sirimaturos M, Hicklen R, Nates JL. Evaluating mortality in cancer patients treated in the intensive care units with sepsis: a systematic review and meta-analysis, 2022. e-Pub 2022.
Nazer L, Brown AR, Cuenca J, Lopez-Olivo MA, Sirimaturos M, Khader H, AlQadheeb N, Heather M, Milano V, Taylor A, Nates J. Septic shock mortality reported in clinical trials in the last decade: a systematic review, 2022. e-Pub 2022.
Lopez-Olivo MA, Ruiz JI, Duhon GF, Altan M, Tawbi H, Diab A, Bingham C, Calabrese C, Volk R, Suarez-Almazor ME. Learning needs assessment for patients with cancer and a pre-existing autoimmune disease who are candidates to receive immune checkpoint inhibitors 81(1):1826, 2022. e-Pub 2022.
Nazer L, Brown AR, Cuenca J, Lopez-Olivo MA, Sirimaturos M, Khader H, AlQadheeb N, Heather M, Milano V, Taylor A, Nates J. A meta-analysis evaluating outcomes of critically ill cancer patients by geographical region, 2022. e-Pub 2022.
Talwar A, Chatterjee S, Lopez-Olivo MA, Aparasu RR. Anticholinergic medications and riks of dementia in older adults: A Meta-analysis of recent literature, 2022. e-Pub 2022.
Lopez-Olivo MA, James J, James J, Krause K, Roth M, Palos GR, Ma H, Rodriguez A, Gilmore K, Cinciripini P, Suarez-Almazor ME. Electronic cigaretter use and characteristics associated to its use among cancer survivors: a systematic review and meta-analysis, 2022. e-Pub 2022.
Lopez-Olivo MA, Kachira J, Buni M, Kim ST, Lu H, Duhon G, Ruiz JI, Bingham III CO, Calabrese C, Volk RJ, Suarez-Almazor ME. Learning needs assessment for patients with cancer and a pre-existing autoimmune disease who are candidates to receive immune checkpoint inhibitors(1), 2022. e-Pub 2022.
Lopez -Olivo MA, Ruiz JI, Duhon G, Altan M, Tawbi H, Diab A, Bingham III CO, Calabrese C, Heredia NI, Volk RJ, Suarez-Almazor ME. Priority educational topics to deliver information about immune checkpoint inhibitors for patients with cancer and a pre-existing autoimmune disease(1), 2022. e-Pub 2022.
Reid P, Sandigursky S, Lopez-Olivo MA, Song J, Safa H, Cytryn S, Buni M, Pavlick A, Krogsgaard, PhD M, Abu-Shawer O, Altan M, Weber J, Suarez-Almazor M, Diab A, Abdel-Wahab N. Safety and effectiveness of immune checkpoint inhibitors combination versus single agent therapy in patients with pre-existing autoimmune diseases 74(9), 2022. e-Pub 2022.
Nazer L, Brown AR, Cuenca J, Lopez -Olivo MA, Sirimaturos M, Khader H, AlQadheeb N, Heather M, Milano V, Taylor A, Nates J. Systematic review and meta-analysis of mortality in cancer patients treated in intensive care units, 2022. e-Pub 2022.
Nazer L, Brown AR, Cuenca J, Lopez-Olivo MA, Sirimaturos M, Khader H, AlQadheeb N, Heather M, Milano V, Taylor A, Nates J. A systematic review evaluating mortality in critically Ill cancer patients with sepsis, 2022. e-Pub 2022.
Tan NQP, Nishi SPE, Lowenstein LM, Mendoza TR, Lopez-Olivo MA, Crocker LC, Sepucha K, Volk RJ. Impact of the shared decision-making process on lung cancer screening decisions, 2021. e-Pub 2021.
Talwar A, Huang Y, Lopez-Olivo MA, Aparasu RR. Comparative performance of logistic regression and machine learning algorithms for hospital readmissions: a systematic review and meta-analysis, 2021. e-Pub 2021.
Manzano JG, Sharma S, Lopez-Olivo MA, Suarez-Almazor ME. Association of diabetes treatment with breast cancer outcomes: a systematic review and meta-analysis, 2020. e-Pub 2020.
Karpes-Matusevich A, Lal LS, Chan W, Swint JM, Cantor SB, Suarez-Almazor ME, Lopez-Olivo MA. Discontinuation plays a role when evaluating the cost effectiveness of the second biological drug for patients with rheumatoid arthritis, 2020. e-Pub 2020.
Lopez-Olivo MA, Maki KG, Choi NJ, Hoffman RM, Shih YCT, Lowenstein LM, Hicklen RS, Volk RJ. Patients' adherence to screening for lung cancer in the United States: a systematic review and meta-analysis, 2020. e-Pub 2020.
Karpes-Matusevich A, Lal LS, Chan W, Swint JM, Cantor SB, Suarez-Almazor ME, Lopez -Olivo MA. Cost-utility analysis of treatment options after initial tumor necrosis factor inhibitor therapy failure in patients with rheumatoid arthritis, 2020. e-Pub 2020.
Lopez -Olivo MA, Volk R, Krause K, Suarez-Almazor ME. A review of smoking cessation strategies and lung cancer screening practices in patients with rheumatoid arthritis 79(Suppl 1): 1422, 2020. e-Pub 2020.
Lopez -Olivo MA, Colmegna I, Karpes AR, Qi SR, Zamora NV, Pratt G, Suarez-Almazor ME. Systematic review of recommendations on the pharmacological management of cancer survivors with concomitant rheumatoid arthritis, 2019. e-Pub 2019.
Volk RJ, Lowenstein LM, Nishi SPE, Mendoza TR, Crocker LC, Lopez-Olivo MA, Choi N, Sepucha K. The quality of lung cancer screening decisions by patients at two academic cancer centers. Abstract presented at the 10th International Shared Decision-Making Conference, ISDM 2019, Quebec, Canada, 2019. e-Pub 2019.
des Bordes J, Foreman J, Lopez -Olivo MA, Peterson S, Westrich-Robertson T, Hofstetter C, Lyddiatt A, Leong A, Suárez-Almazor M. Physical challenges in RA: a qualitative study of an online patient support group 71 (Suppl 10), 2019. e-Pub 2019.
Lopez-Olivo MA, des Bordes JKA, Pratt G, Suarez-Almazor M. Prescriber attitudes and beliefs about triple therapy for patients with rheumatoid arthritis: knowledge exchange in internet forums and social media, 2019. e-Pub 2019.
Tannenbaum D, Raghav KPS, Horn RA, Overman MJ, Eng C, Kopetz S, Johnson B, Morris V, Parseghian CM, Chang GJ, Rogers JE, Parker S, Lopez-Olivo MA, Dasari A. Systematic review of three decades of clinical trials in metastatic colorectal cancer: Making lemonade out of lemons? 4(suppl), 2019. e-Pub 2019.
Lopez-Olivo MA, Abdel-Wahab N, Suárez-Almazor M. A systematic review and meta-analysis of observational studies reporting on the use of checkpoint inhibitors in patients with cancer and pre-existing autoimmune disease 71 (Suppl 10), 2019. e-Pub 2019.
Yap A, Lopez-Olivo MA, Dubowitz J, Hiller J, Riedel B. Collaboration G Anesthetic technique, and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia Australian and New Zealand College of Anaesthetists (ANZCA), 2019. e-Pub 2019.
Yap A, Lopez-Olivo MA, Dubowitz J, Hiller J, Riedel B. Anaesthetic technique and cancer outcomes: a meta-analysis of total intravenous vs. volatile anaesthesia 66(5):546-561, 2019. e-Pub 2019.
Abdel-Wahab N, Houssein S, Lopez-Olivo MA, Diab A, Suarez-Almazor ME. Checkpoint inhibitors in patients with cancer and rheumatologic diseases: a systematic review of the literature volume 78, supplement Suppl, year 2019, 2019. e-Pub 2019.
Karpes A, Duan Z, Zhao H, Lal L, Chan W, Suárez-Almazor M, Giordano S, Swint J, Lopez-Olivo MA. Treatment sequences, effectiveness, and costs of tumor necrosis factor inhibitor cycling compared with swapping to a novel disease-modifying anti-rheumatic drug in rheumatoid arthritis patients 71 (Suppl 10), 2019. e-Pub 2019.
Lopez-Olivo MA, Foreman J, Lin H, Leung CH, Westrich-Robertson T, Hofstetter C, Peterson SK, Lyddiatt A, Leong AL, Willcockson IU, Suarez-Almazor M. Effects of social networking on chronic disease management in rheumatoid arthritis, 2018. e-Pub 2018.
Lopez-Olivo MA, Tayar J, Zamora N, Pratt G, Suarez-Almazor M. Malignancies, and serious infections in randomized controlled trials of janus kinase inhibitors in patients with rheumatoid arthritis: a systematic review and meta-analysis 70 (Suppl 9):66, 2018. e-Pub 2018.
Lopez-Olivo MA, Matusevich A, Cantor SB, Pratt G, Suarez-Almazor M. The comparative effectiveness of cycling tumor necrosis factor inhibitor (TNFi) versus swapping to a nonTNFi on patient-reported functional ability of patients with rheumatoid arthritis 70 (Suppl 9):6-26, 2018. e-Pub 2018.
Laserna A, Duran-Crane A, Lopez-Olivo MA, Diaz DP, O'Connell K, Cuenca JA, Fowler C, Nates JL. Pain Management of end-of-life patients undergoing withholding and withdrawal of life support in the intensive care unit: a systematic review, 2018. e-Pub 2018.
Pundole X, Lopez-Olivo MA, Suarez-Almazor M, Lu HF. Anti-sclerostin antibodies for the treatment of osteoporosis: a systematic review and meta-analysis 33(Suppl 1), 2018. e-Pub 2018.
Lopez-Olivo MA, des Bordes JKA, Pratt G, Suarez-Almazor M. Prescriber attitudes and beliefs about triple therapy for patients with rheumatoid arthritis: knowledge exchange in internet forums and social media 70 (Suppl 10), 2018. e-Pub 2018.
Lopez-Olivo MA, Foreman J, Lin H, Leung CH, Westrich-Robertson T, Hofstetter C, Peterson SK, Lyddiatt A, Leong AL, Willcockson IU, Suarez-Almazor M. Effects of social networking on chronic disease management in rheumatoid arthritis 70(Suppl 9):19-26, 2018. e-Pub 2018.
Zogala R, Criner K, Lopez-Olivo MA, Zamora N, Rai D, Pratt G, des Bordes JKA, Christensen R, Suarez-Almazor M. Patient-reported outcome measures used in rheumatoid arthritis cohorts and registries around the world: an environmental scan from the outcome measures in rheumatology critical outcomes in longitudinal observational studies working group 70 (Suppl 10), 2018. e-Pub 2018.
Matusevich A, Suarez-Almazor M, Cantor SB, Lopez -Olivo MA. Systematic review of modelling approaches and quality for the cost effectiveness of sequential targeted therapy in patients with rheumatoid arthritis that show an inadequate response to at least one tumor necrosis factor alpha inhibitor 69 (Suppl 10), 2017. e-Pub 2017.
des Bordes J, Prasad S, Pratt G, Suarez-Almazor M, Lopez-Olivo MA. Knowledge, beliefs, and concerns about osteoporosis - a qualitative synthesis 69 (Suppl 10), 2017. e-Pub 2017.
des Bordes JKA, Foreman J, Peterson SK, Lopez-Olivo MA, Westrich-Robertson T, Hofstetter C, Lyddiatt A, Leong AL, Suarez-Almazor ME. Experiences, and perceptions of patients with rheumatoid arthritis participating in an online support group: the use of social media 69 (Suppl 10):118, 2017. e-Pub 2017.
Lopez-Olivo MA, Colmegna I, Matusevich A, Q SR, Zamora N, Sharma R, Pratt G, Suarez-Almazor ME. Recommendations on the management of rheumatoid arthritis in patients with cancer: a systematic review of clinical practice guidelines and consensus statements 69 (Suppl 10), 2017. e-Pub 2017.
Lopez-Olivo MA, Matusevich A, Suarez-Almazor M. Cycling versus swapping in patients with rheumatoid arthritis with an inadequate response to at least one tumor necrosis factor alpha inhibitor: a systematic review and meta-analysis of observational studies 69 (Suppl 10):2483, 2017. e-Pub 2017.
Lopez-Olivo MA, Matusevich A, Suarez-Almazor ME. Cycling versus swapping in patients with rheumatoid arthritis with an inadequate response to at least one tumor necrosis factor alpha inhibitor: a systematic review and meta-analysis of observational studies 76(Suppl 2):851, 2017. e-Pub 2017.
Abdel-Wahab N, Shah M, Lopez-Olivo MA, Suarez-Almazor M. A Systematic review of the management of patients with preexisting rheumatologic diseases receiving checkpoint inhibitors for cancer 69 (Suppl 10):21-28, 2017. e-Pub 2017.
Zamora N, Lopez -Olivo MA, Tayar J, Christensen R, Suarez-Almazor M. Comparative effectiveness of tofacitinib versus baricitinib in rheumatoid arthritis using a systematic review and network meta-analysis of randomized trials 69 (Suppl 10):531, 2017. e-Pub 2017.
Chhatwal J, He T, Hur C, Lopez-Olivo MA. Cost-effectiveness of direct-acting antivirals for HCV treatment: a systematic review of 227 analyses, 2016. e-Pub 2016.
Zamora NV, Lopez-Olivo MA, Christensen R, Goel N, Kristensen LE, Strand V, Curtis JR, Shea B, Suarez-Almazor M. Environmental scan of rheumatoid arthritis patient registries around the world: an OMERACT initiative 68 (Suppl 10):1221, 2016. e-Pub 2016.
Lopez-Olivo MA, des Bordes J, Volk R, Lu H, Edwards B, Suarez-Almazor ME. Development, and beta testing of educational websites on bone health in cancer survivors, 2016. e-Pub 2016.
des Bordes J, Pratt G, Suarez-Almazor ME, Lopez-Olivo MA. Pilot testing an educational website on bone health in cancer survivors, 2016. e-Pub 2016.
des Bordes J, Pratt G, Suarez-Almazor ME, Lopez-Olivo MA. Knowledge, beliefs, and concerns about low bone density - a qualitative synthesis, 2016. e-Pub 2016.
Pundole X, Lopez-Olivo MA, Cheema H, Sanchez Petitto G, Suarez-Almazor ME, Lu H. Prevention and treatment of bone loss following hematopoietic stem cell transplantation: a systematic review and meta-analysis, 2016. e-Pub 2016.
Barbo A, Suarez-Almazor M, Lopez-Olivo MA. Impact of decision-making role preferences in the efficacy of a multimedia patient education tool for patients with common rheumatologic conditions 68 (Suppl 10), 2016. e-Pub 2016.
Yap A, Dubowitz J, Lopez-Olivo MA, Hernandez M, Pratt G, Hiller J, Gottumukkala V, Sloan E, Riedel G, Schier R. Effect of beta blockers on cancer recurrence, disease-free survival, and overall survival: a meta-analysis, 2016. e-Pub 2016.
Zamora NV, Tayar J, Lopez-Olivo MA, Christensen R, Suarez-Almazor ME. Baricitinib for rheumatoid arthritis: a systematic review and meta-analysis 75 (Suppl 2):731-732, 2016. e-Pub 2016.
Lopez-Olivo MA, des Bordes J, Volk R, Lu H, Edwards B, Suarez-Almazor ME. Development, and beta testing of educational websites on bone health in cancer survivors, 2016. e-Pub 2016.
Zamora NV, Tayar J, Lopez-Olivo MA, Christensen R, Suarez-Almazor M. Baricitinib for rheumatoid arthritis: a systematic review and meta-analysis 68 (Suppl 10):1513, 2016. e-Pub 2016.
Abdel-Wahab N, Lopez-Olivo MA, Suarez-Almazor M. Antiphospholipid antibodies and related clinical events following infection in children: a systematic review of case reports 68 (Suppl 10):1060, 2016. e-Pub 2016.
Garcia SR, Lopez-Olivo MA, Suarez-Almazor M. Treatments for early rheumatoid arthritis (RA): a systematic review of randomized controlled trials 68 (Suppl 10), 2016. e-Pub 2016.
Lopez-Olivo MA, Matusevich A, Suarez-Almazor M. Therapy in patients with rheumatoid arthritis (RA) with inadequate response to tumor necrosis factor alpha inhibitors (TNFi): a systematic review and meta-analysis of randomized controlled trials (RCTs) [abstract] 68 (Suppl 10), 2016. e-Pub 2016.
des Bordes J, Pratt G, Suarez-Almazor ME, Lopez-Olivo MA. Pilot testing an educational website on bone health in cancer survivors, 2016. e-Pub 2016.
des Bordes J, Pratt G, Suarez-Almazor ME, Lopez-Olivo MA. Knowledge, beliefs, and concerns about low bone density - a qualitative synthesis, 2016. e-Pub 2016.
Zamora NV, Lopez-Olivo MA, Christensen R, Goel N, Kristensen LE, Strand V, Curtis J, Shea B, Suarez-Almazor ME. Environmental scan of rheumatoid arthritis patient registries around the world: an OMERACT initiative, 2016. e-Pub 2016.
Anand V, Anand S, Garg SK, Lopez-Olivo MA, Singh JA. Ofatumumab for rheumatoid arthritis: a cochrane systematic review and meta-analysis, 2015. e-Pub 2015.
Basra G, Cardenas-Turanzas M, Andrabi T, French KE, Bellard B, Jr MW, Lopez-Olivo MA, Suarez-Almazor ME. Fiber optic intubation in patients with rheumatoid arthritis who had a surgical procedure 67 (Suppl 10), 2015. e-Pub 2015.
Lopez-Olivo MA, Ojeda-Prias A, Heung E, Leong AL, Willcockson I, Suarez-Almazor ME. Quality assessment of websites providing educational content about rheumatoid arthritis 67 (Suppl 10), 2015. e-Pub 2015.
Cardenas-Turanzas M, Gonzalez E, Shethia M, Lopez-Olivo MA, Nayak P, Suarez-Almazor ME. Assessing information needs for chronic disease management in rheumatoid arthritis 67 (Suppl 10), 2015. e-Pub 2015.
Valerio-Morales IA, Lopez-Olivo MA, Pan X, Suarez-Almazor ME. A phosphodiesterase 4 inhibitor for psoriatic arthritis: systematic review and meta-analysis 67 (Suppl 10):2858, 2015. e-Pub 2015.
Anand V, Anand S, Garg S, Lopez-Olivo MA, Singh JA. Ofatumumab for rheumatoid arthritis: a Cochrane systematic review and meta-analysis 67 (Suppl 10):500, 2015. e-Pub 2015.
Lopez-Olivo MA, Barbo A, Rizvi T, Volk R, Lin H, Suarez-Almazor ME. Improving outcomes with a multimedia patient education tool in patients with osteoporosis after 6 months. A randomized controlled trial 67 (Suppl 10):2219, 2015. e-Pub 2015.
des Bordes J, Hassan N, Suarez-Almazor ME, Lopez-Olivo MA. Assessing information needs on bone health among cancer survivors, 2015. e-Pub 2015.
Pundole X, Lopez-Olivo MA, Cheema H, Sanchez Petitto G, Suarez-Almazor ME, Lu H. Prevention and treatment of bone loss following hematopoietic stem cell transplantation: a systematic review and meta-analysis 67 (Suppl 10):367, 2015. e-Pub 2015.
Lopez-Olivo MA, Barbo A, Rizvi T, Volk R, Lin H, Suarez-Almazor ME. Six-Month effects of a multimedia patient education tool in patients with rheumatoid arthritis. A randomized controlled trial 67 (Suppl 10), 2015. e-Pub 2015.
Lopez-Olivo MA, Abdel-Wahab N, Dodeja A, Pratt G, Suarez-Almazor ME. Quality appraisal of educational websites on osteoporosis and bone health, 2015. e-Pub 2015.
Lopez-Olivo MA, Barbo A, Rizvi T, Volk R, Lin H, Suarez-Almazor ME. A randomized controlled trial to evaluate a multimedia patient education tool in patients with knee osteoarthritis. Six-month results 67 (Suppl 10), 2015. e-Pub 2015.
Kakpovbia V, Lopez-Olivo MA, Des Bordes J, Christensen R, Suarez-Almazor ME. The treatment of undifferentiated arthritis: a systematic review and meta-analysis of randomized clinical trials 67 (Suppl 10):1406, 2015. e-Pub 2015.
Abdel-Wahab N, Lopez-Olivo MA, Talathi S, Suarez-Almazor ME. Risk of developing antiphospholipid syndrome following infection: a systematic review and meta-analysis of observational studies, 2015. e-Pub 2015.
Pan X, Lopez-Olivo MA, Nayak P, Suarez-Almazor ME. Quality assessment of controlled trials evaluating Chinese herbal medicine in patients with rheumatoid arthritis: a systematic review 17(7):A547, 2014. e-Pub 2014. PMID: 27201776.
Bruera S, Lopez-Olivo MA, Barbo A, Suarez-Almazor ME. Use of medication reminders in patients with rheumatoid arthritis 17(7):A384, 2014. e-Pub 2014. PMID: 27200863.
Anand V, Anand S, Garg SK, Lopez-Olivo MA, Singh JA. Ofatumumab for rheumatoid arthritis: a cochrane systematic review and meta-analysis, 2014. e-Pub 2014.
Abdelwahab Hassan N, Lopez-Olivo MA, Siddhanamatha HR, Suarez-Almazor ME. The relationship between infection and anti-phospholipid syndrome: A systemic review of case reports, 2014. e-Pub 2014.
Pan X, Lopez-Olivo MA, Nayak P, Suarez-Almazor ME. Quality assessment of controlled trials evaluating Chinese herbal medicine in patients with rheumatoid arthritis: a systematic review 66 (11 Suppl)(S1055), 2014. e-Pub 2014.
McGahan L, Lopez-Olivo MA, Amezaga M, Polono NE, Suarez-Almazor ME. Rituximab in rheumatoid arthritis, 2014. e-Pub 2014.
Abdel-Wahab N, Lopez-Olivo MA, Patarroyo-Pinto P, Suarez-Almazor ME. Antiphospholipid syndrome following infection: a systematic review of case reports. Arthritis Rheum (Suppl) 66(11)(S8), 2014. e-Pub 2014.
Ingleshwar A, Lopez-Olivo MA, Volk R, Barbo A, Jibaja-Weiss M, Lin H, Suarez-Almazor ME. Multimedia patient education tool for patients with osteoarthritis. Arthritis Rheum (Suppl) 66(11)(S976), 2014. e-Pub 2014.
Peddi M, Lopez-Olivo MA, Peddi P, Espinosa-Cuervo G, Suarez-Almazor M. Physical therapy for systemic sclerosis: systematic review and meta-analysis. Arthritis Rheum (Suppl) 66(11)(S737), 2014. e-Pub 2014.
Abdelwahab Hassan N, Lopez-Olivo MA, Siddhanamatha HR, Suarez-Almazor ME. The relationship between infection and anti-phospholipid syndrome: A systemic review of case reports 73 (Suppl 3)(608), 2014. e-Pub 2014.
Abdel-Wahab N, Lopez-Olivo MA, Talathi S, Suarez-Almazor ME. Risk of developing antiphospholipid syndrome following infection: a systematic review and meta-analysis of observational studies. Arthritis Rheum (Suppl) 66(11)(S432), 2014. e-Pub 2014.
Lopez-Olivo MA, Ingleshwar A, Volk R, Barbo A, Jibaja-Weiss M, Lin H, Suarez-Almazor ME. Multimedia patient education tool for patients with rheumatoid arthritis. Arthritis Rheum (Suppl) 66(11)(S182), 2014. e-Pub 2014.
Lopez-Olivo MA, Abdel-Wahab N, Dodeja A, Pratt G, Suarez-Almazor ME. Quality appraisal of educational websites on osteoporosis and bone health. Arthritis Rheum (Suppl) 66(11)(S884), 2014. e-Pub 2014.
Lopez-Olivo MA, Ingleshwar A, Volk R, Barbo A, Jibaja-Weiss M, Lin H, Suarez-Almazor ME. Multimedia patient education tool for patients with osteoporosis. Arthritis Rheum (Suppl) 66(11)(S880), 2014. e-Pub 2014.
Lopez-Olivo MA, Ingleshwar A, Volk R, Barbo A, Jibaja-Weiss M, Leong A, Saag K, Suarez-Almazor ME. Development of multimedia patient education tools (MM-PtET) for osteoarthritis (OA), osteoporosis (OP) and rheumatoid arthritis patients (RA). Arthritis Rheum (Suppl) 66(11)(S882), 2014. e-Pub 2014.
Lopez-Olivo, MA, Bavineni, M, Suarez-Almazor, M. Tofacitinib for rheumatoid arthritis 2013(4), 2013. e-Pub 2013.
Lopez-Olivo MA, Martinez-Lopez JA, Tayar JH, Bavineni M, Fulton S, Suarez-Almazor ME. Adverse events with the use of radiotherapy in patients with connective tissue diseases and cancer: a systematic review and meta-analyses. Arthritis Rheum 65(10)(Supp:297), 2013. e-Pub 2013.
Lopez-Olivo MA, Martinez-Lopez JA, Tayar JH, Bavineni M, Fulton S, Suarez-Almazor ME. Adverse events with the use of radiotherapy in patients with connective tissue diseases and cancer 72(Suppl 3), 2013. e-Pub 2013.
Ingleshwar A, Lopez-Olivo MA, Volk R, Suarez-Almazor ME. A pilot study to evaluate a multi-media patient decision aid (MM-PtDa) for osteoarthritis (OA), osteoporosis (OP) and rheumatoid arthritis (RA) patients, 2013. e-Pub 2013.
Lopez-Olivo MA, Martinez-Lopez JA, Tayar JH, Bavineni M, Fulton S, Suarez-Almazor ME. A meta-analysis on the use of radiotherapy in patients with connective tissue diseases and cancer, 2013. e-Pub 2013.
Rodriguez S, Lopez-Olivo MA, Richards V, Volk R, Suarez-Almazor ME. A pilot study to evaluate a multi-media patient decision aid for osteoporosis patients, 2013. e-Pub 2013.
Lopez-Olivo MA, Volk R, Lu H, Suarez-Almazor ME. An educational web page about bone health in cancer survivors, 2013. e-Pub 2013.
Ingleshwar A, Lopez-Olivo MA, Landon GC, Siff SJ, Barbo A, Suarez-Almazor ME. Psychosocial determinants of total knee arthroplasty outcomes 2 years after surgery. Arthritis Rheum 65(10)((Suppl:352)), 2013. e-Pub 2013.
Lopez-Olivo MA, Volk R, Jibaja-Weiss M, Suarez-Almazor ME. Preferred strategies for delivering treatments information to people with rheumatoid arthritis. Arthritis Rheum 65(10)((Suppl:419)), 2013. e-Pub 2013.
Peddi P, Lopez-Olivo MA, Pratt G, Suarez-Almazor M. Denosumab in patients with cancer and skeletal metastases, 2012. e-Pub 2012.
Lopez-Olivo MA, Pratt G, Salahudeen A. Rasburicase for the treatment and prevention of tumor lysis sundrome in adults, 2012. e-Pub 2012.
Shah N, Pratt G, Suarez-Almazor M, Lopez-Olivo MA. Efficacy of bisphosphonates for bone metastases in patients with lung cancer: a systematic review and meta-analysis, 2011. e-Pub 2011.
Waimann CA, Fernandez-Mazarambroz RJ, Cantor S, Lopez-Olivo MA, Zhang H, Landon GC, Siff SJ, Suarez-Almazor ME. Impact of psychosocial determinants on total knee replacement (TKR) costs: results from the patient expectations about knee surgery (PEAKS) cohort. Arthritis Rheum 63(Suppl 10):S345, 2011. e-Pub 2011.
Waimann CA, Fernandez-Mazarambroz RJ, Cantor S, Lopez-Olivo MA, Zhang H, Landon GC, Siff SJ, Suarez-Almazor ME. Impact of slow recovery and poor functional outcomes on direct and indirect costs after total knee replacement in osteoarthritis patients. Arthritis Rheum 63(Suppl 10):S347, 2011. e-Pub 2011.
Marengo MF, Waimann CA, Lopez-Olivo MA, Looney C, Suarez-Almazor ME. Controversies in the use of acupuncture for osteoarthritis (OA): a systematic review of the quality and treatment features of randomized clinical trials (RCT). Arthritis Rheum 62(Suppl):S389-90, 2010. e-Pub 2010.
Lopez-Olivo MA, Shaw Y, Suarez-Almazor ME. A systematic review to appraise the quality of cost-effectiveness studies of biologic agents for the treatment of rheumatoid arthritis. Arthritis Rheum 62(Suppl):S315, 2010. e-Pub 2010.
Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, Tanjong Ghogomu E, Tugwell P. A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview, 2010. e-Pub 2010.
Lopez-Olivo MA, Martinez-Lopez JA, Polo Cueto J, Pollono EN, Gonzalez-Crespo MR, Fulton S, Suarez-Almazor ME. Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: meta-analysis of controlled trials, 2010. e-Pub 2010.
Lopez-Olivo MA, Martinez-Lopez JA, Tayar JH, Polo Cueto J, Pollono EN, Gonzales-Crespo MR, Fulton S, Suarez-Almazor ME. Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: meta-analysis of controlled trials. Arthritis Rheum 62(Suppl):S171-2, 2010. e-Pub 2010.
Lopez-Olivo MA, Kallen MA, Pak CH, Siff SJ, Landon GC, Edelstein D, Robinson KC, Suarez-Almazor ME. Using the patient generated index (PGI) to measure personalized quality of life (QoL) in patients undergoing total knee arthroplasty (TKA), 2010. e-Pub 2010.
Lopez-Olivo MA, Suarez-Almazor ME, Shaw Y. A systematic review to appraise the quality of cost-effectiveness studies of biologic agents for the treatment of rheumatoid arthritis. Ann Rheum Dis 69(Suppl3):642, 2010. e-Pub 2010.
Lopez-Olivo MA, Tayar JH, Suarez-Almazor ME. Febuxostat for the treatment of chronic recurrent gout: a meta-analysis. Ann Rheum Dis 69(Suppl 3):608, 2010. e-Pub 2010.
Lopez-Olivo MA, Kallen M, Pak C, Siff SJ, Landon GC, Edelstein D, Robinson KC, Zhang H, Suarez-Almazor ME. Psychosocial and educational barriers to surgical success after knee arthroplasty. Arthritis Rheum 60(Suppl 10), 2009. e-Pub 2009.
Lopez-Olivo MA, Andrabi TR, Suarez-Almazor ME. Cervical spine instability in patients with rheumatoid arthritis undergoing cancer-related surgeries and procedures, 2008. e-Pub 2008.
Alcaraz-Lopez MF, Aguilar-Chavez EA, Sandoval-Ramirez L, Loaiza-Cardenas CA, Lopez-Olivo MA, Salazar-Paramo M, Davalos-Rodriguez IP, Martinez-Corral ME, Gamez-Nava JI, Gonzalez-Lopez L. Clinical, epidemiological factors and TAQI genotype of the vitamin D receptor in osteoporosis associated with rheumatoid arthritis. Ann Rheum Dis 66(Suppl II):591, 2007. e-Pub 2007.
Gossec L, Jordan JM, Mazzuca SM, Lam MA, Suarez-Almazor ME, Renner JB, Lopez-Olivo MA, Hawker G, Dougados M, Maillefert JF, travail OARSI-OMERACT GD. La mesure de l’interligne articulaire est un meilleur indice structural dans la gonarthrose que les scores semi-quantitatifs : étude comparative de 3 méthodes d’évaluation de l’arthrose dans 1759 radiographies, 2007. e-Pub 2007.
Lopez-Olivo MA, Roundtree AK, Skidmore B, Suarez-Almazor ME. A systematic review on the occurrence of cancer in patients with rheumatoid arthritis while on treatment of anti-TNF-α agents. Division of Internal Medicine Research Retreat(Abstract C3), 2007. e-Pub 2007.
Suarez-Almazor ME, Roundtree AK, Kallen MA, Lopez-Olivo MA, Ortiz Z, Skidmore B. Systematic review of reviews on the use of biologics for rheumatoid arthritis. Arthritis Rheum 56(Suppl 9), 2007. e-Pub 2007.
Lopez-Olivo MA, Suarez-Almazor ME, Moffett ML. Economic evaluation of biologic therapies in ankylosing spondylitis: a systematic review. Ann Rheum Dis 66(Suppl II):274, 2007. e-Pub 2007.
Lopez-Olivo MA, Andrabi TR, Suarez-Almazor ME. Cervical spine instability in patient with rheumatoid arthritis (RA) undergoing general surgery. Arthritis Rheum 56(Suppl 9), 2007. e-Pub 2007.
Lopez-Olivo MA, Kallen MA, Richardson MN, Garcia-Gonzalez A, Cox VL, Lidsky M, Ng B, Marcus D, Reveille JD. Treatment adherence and use of reminders in patients with rheumatic disease. Arthritis Rheum 56(Suppl 9:110), 2007. e-Pub 2007.
Lopez-Olivo MA, Kallen MA, Pak CH, Siff SJ, Landon GC, Eldestein D, Suarez-Almazor ME. Role of social support and depression on pain and function in patients undergoing total knee arthroplasty (TKA). Arthritis Rheum 56(Suppl 9), 2007. e-Pub 2007.
Lopez-Olivo MA, Kallen MA, Richardson MN, Garcia-Gonzalez A, Cox VL, Lidsky L, Ng B, Marcus D, Reveille JD. Effect of depression and social support on the self-reported adherence in patients with rheumatic diseases. Arthritis Rheum 56(Suppl 9:):118, 2007. e-Pub 2007.
Lopez-Olivo MA, Kallen M, Ortíz Z, Kendall Roundtree A, Skidmore B, Suárez-Almazor M. Validez científica de las guías de práctica clínica sobre el uso del infliximab, etanercept y adalimumab en artritis reumatoide, 2007. e-Pub 2007.
Gossec L, Jordan JM, Lam M, Suarez-Almazor ME, Mazzuca S, Renner JB, Lopez-Olivo MA, Hawker G, Dougados M, Maillefert J. Measurement of joint space width appears to be the most valid indicator of structural damage in knee osteoarthritis: a comparative study of 3 radiographic scores in 1759 x-rays. Ann Rheum Dis 66(Suppl II):58, 2007. e-Pub 2007.
Lopez-Olivo MA, Roundtree AK, Ortiz Z, Skidmore B, Suarez-Almazor ME. Switching between anti-TNF agents’ treatments for rheumatoid arthritis: a systematic review. Ann Rheum Dis 66(Suppl II):189, 2007. e-Pub 2007.
Suarez-Almazor ME, Lopez-Olivo MA, Pak CH, Skidmore B. Long-term effectiveness during infliximab or etanercept therapy: A systematic review of observational studies. Arthritis Rheum 56(Suppl 9), 2007. e-Pub 2007.
Lopez-Olivo MA, Kallen MA, Ortiz Z, Roundtree AK, Skidmore B, Suarez-Almazor ME. Scientific validity of clinical practice guidelines for the use of infliximab and etanercept in rheumatoid arthritis. Arthritis Rheum 56(Suppl 9), 2007. e-Pub 2007.
Gonzalez-Lopez L, Sanchez-Hernandez JD, Aguilar-Chavez EA, Villa-Manzano AI, Cota-Sánchez AR, Lopez-Olivo MA, Alonso-Gamiño L, Espinoza-Magaña GLC, Cardona-Muñoz EG, Rojo-Contreras EW, Gamez-Nava JI. Hyperhomocysteinemia in ankylosing spondylitis. Ann Rheum Dis 66(Suppl II):613, 2007. e-Pub 2007.
Suarez-Almazor ME, Lopez-Olivo MA, Pak C, Ortiz Z, Cox VL, Skidmore B. Long-term effectiveness during infliximab or etanercept therapy: a systematic review of observational studies. Ann Rheum Dis 66(Suppl II):601, 2007. e-Pub 2007.
Lopez-Olivo MA, Moffett MM, Kallen MA, Ortiz Z, Skidmore B, Suarez-Almazor ME. Economic evaluation of infliximab and etanercept: a systematic review 65((Suppl 2)):329, 2007. e-Pub 2007.
Corona-Sanchez EG, Gonzalez-Lopez L, Ayala-Lopez K, Aguilar-Chavez EA, Munoz-Valle F, Galvan-Melendez S, Loaiza-Cardenas C, Lopez-Olivo MA, Ortega-Flores R, Salazar-Paramo M, Vazquez-Del Mercado M, Gamez-Nava JI. Levels of serum soluble E-selectin in active rheumatoid arthritis. Arthritis Rheum 54((9:Suppl)):379, 2006. e-Pub 2006.
Suarez-Almazor ME, Lopez-Olivo MA, Kendall-Roundtree A, Ortiz Z, Skidmore B. Dose escalation in anti-TNF therapy for rheumatoid arthritis (RA): a systematic review 65(Suppl 2):603, 2006. e-Pub 2006.
Lopez-Olivo MA, Garcia-Gonzalez A, Kallen MA, Richardson MN, Cox VL, Janssen NM, Marcus DM, Reveille JD, Warner NB, Suarez-Almazor ME. Social support, and quality of life in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Arthritis Rheum 54((9:Suppl)):335-6, 2006. e-Pub 2006.
Corona-Sanchez EG, Gonzalez-Lopez L, Ayala-Lopez K, Aguilar-Chavez EA, Munoz-Valle F, Galvan-Melendez S, Loaiza-Cardenas C, Lopez-Olivo MA, Ortega-Flores R, Salazar-Paramo M, Vazquez-Del Mercado M, Gamez-Nava JI. Levels of serum soluble E-selectin in active rheumatoid arthritis [Niveles sericos de E-selectina como marcadores de actividad en artritis reumatoide] 33(2):40, 2006. e-Pub 2006.
Alcaraz-Lopez MF, Gonzalez-Lopez L, Aguilar-Chavez E, Lopez-Olivo MA, Loaiza-Cardenas C, Gamez-Nava JI. Perfomance of albrand index for identifying low bone density in rheumatoid arthritis. J Rheumatol 33((2):Suppl):408-409, 2006. e-Pub 2006.
Rojo Contreras EW, Gonzalez-López L, Ayala Lopez KP, Lopez-Olivo MA, Morales Romero J, Vazquez Salcedo J, Castillo Gonzalez J, Gamez-Nava JI. Disfuncion sexual en lupus eritematoso sistemico 2(1):((40)), 2006. e-Pub 2006.
Rojo Contreras EW, Gonzalez-Lopez L, Ayala Lopez KP, Lopez-Olivo MA, Morales Romero J, Vazquez Salcedo J, Castillo Gonzalez J, Gamez-Nava JI. Disfunción sexual en lupus eritematoso sistémico 2(1):40, 2006. e-Pub 2006.
Lopez-Olivo M, Ortiz Z, Pak CH, Cox V, Kimmel B, Kendall-Roundtree A, Skidmore B, Suarez-Almazor ME. A meta-analysis on the timing of therapeutic introduction of infliximab (IFX) and etanercept (ETN) 65((Suppl 2)):329, 2006. e-Pub 2006.
Lopez-Olivo MA, Moffett ML, Cox VL, Richardson MN, Garcia-Gonzalez A, Suarez-Almazor ME. Association of SF-6D health utilities with activity and side effects in patients with systemic lupus erythematosus. Arthritis Rheum 54((9:Suppl)):335-6, 2006. e-Pub 2006.
Alcaraz-Lopez MF, Gonzalez-Lopez L, Aguilar-Chavez EA, Lopez-Olivo MA, Cardenas-Chavez O, Trujillo-Hernandez B, Salazar-Paramo M, Martinez-Corral ME, Gamez-Nava JI. Prevalencia de osteoporosis en mujeres con artritis reumatoide en un hospital de segundo nivel de atención 2(1:71), 2006. e-Pub 2006.
Aguilar-Chavez EA, Gonzalez-Lopez L, Lopez-Olivo MA, Alcaraz-Lopez MF, Corona-Sanchez EG, Galvan-Melendez S, Loaiza-Cardenas C, Varón-Villalpando E, Rojo-Contreras EW, Gamez-Nava JI. Association between serum leptin levels and disease activity in rheumatoid arthritis 65((Suppl II)):628, 2006. e-Pub 2006.
Lopez-Olivo MA, Garcia-Gonzalez A, Kallen MA, Richardson MN, Cox VL, Janssen NM, Marcus DM, Reveille JD, Warner NB, Suarez-Almazor ME. Social support and quality of life in patients with rheumatoid arthritis 33(2):422-423, 2006. e-Pub 2006.
Lopez-Olivo MA, Moffett ML, Kallen MA, Ortiz Z, Skidmore B, Suarez-Almazor B. Economic evaluation of infliximab and etanercept: A systematic review. Arthritis Rheum 54((9:Suppl)):336, 2006. e-Pub 2006.
Sandoval Ramirez L, Casillas Avila MP, Alcaraz-López MF, Aguilar-Chavez EA, Lopez-Olivo MA, Davalos Rodriguez IP, Salazar-Paramo M, Gonzalez-López L, Gamez-Nava JI. Frecuencia de polimorfismos del gen receptor de vitamina D en pacientes con artritis reumatoide y controles sanos 2(1):(77), 2006. e-Pub 2006.
Aguilar-Chavez EA, Gonzalez-López L, Lopez-Olivo MA, Galvan-Melendez S, Loaiza-Cardenas C, Alcaraz-Lopez MF, Gamez-Nava JI. Association between serum leptin levels and disease activity in rheumatoid arthritis. J Rheumatol 33((2:Suppl)):409, 2006. e-Pub 2006.
Sanchez-Hernandez JD, Lopez-Olivo MA, Aguilar-Chavez E. Differences in the perception of health-related quality of life between men and women with ankylosing spondylitis. J Rheumatol 33((2):Suppl):408-408, 2006. e-Pub 2006.
Lopez-Olivo M, Ortiz Z, Pak CH, Cox V, Kimmel B, Kendall-Roundtree A, Skidmore B, Suarez-Almazor ME. A meta-analysis on the timing of therapeutic introduction of infliximab (IFX) and etanercept (ETN) 54((9)):243, 2006. e-Pub 2006.
Gamez-Nava JI, Corona-Sanchez E, Aguilar-Chavez E, Muñoz-Valle J, Galvan-Melendez S, Loaiza-Cardenas C, Lopez-Olivo MA, Ortega-Flores R, Salazar-Paramo M, Rojo-Contreras E, Vazquez-Del Mercado M, Gonzalez-Lopez L. Serum-soluble E-selectin levels in active rheumatoid arthritis. Ann Rheum Dis 65(Suppl II):629, 2006. e-Pub 2006.
Corona-Sanchez EG, Gonzalez-Lopez L, Ayala-Lopez K, Aguilar-Chavez EA, Munoz-Valle F, Galvan-Melendez S, Loaiza-Cardenas C, Lopez-Olivo MA, Ortega-Flores R, Salazar-Paramo M, Vazquez-Del Mercado M, Gamez-Nava, JI. Levels of serum soluble E-selectin in active rheumatoid arthritis 2(1):40, 2006. e-Pub 2006.
Casillas-Avila MP, Gonzalez-López L, Lopez-Olivo MA, Alcaraz F, Agilar Chavez EAG, Gamez-Nava JI, Salazar Paramo M, Davalos IP, Figuera LE, Mena-Ramirez JP, Sandoval Ramirez L. Asociación entre la osteoporosis en artritis reumatoide con polimorfismo del gen del receptor de vitamina D, 2006. e-Pub 2006.
Morales-Romero J, Gonzalez-López L, Garcia-Gonzalez A, Lopez-Olivo MA, Villa-Manzano AI, Rosales-Cervantes MC, et al. Motivos y frecuencia de incapacidad laboral en pacientes con artritis reumatoide (AR) y espondilitis anquilosante (EA) 19(1):((21)), 2004. e-Pub 2004.
Gamez-Nava JI, Villa-Manzano AI, Garcia-Gonzalez A, Lopez-Olivo MA, Garcia-Gonzalez G, Valera-Gonzalez I, Salazar-Paramo M, Morales-Romero J, Gonzalez-López L. Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythermatosus. Arthritis Rheum 48((9:Suppl)):1487, 2003. e-Pub 2003.
Morales Romero J, López Sandoval I, Perez Serna JC, Lopez-Olivo MA, Villa Manzano AI, Aguilar Chavez EAG, Gonzalez Lopez L, Gamez Nava JI. Physician’s behavior regarding the use of alternative medicine in patients with rheumatoid arthritis, 2003. e-Pub 2003.
Garcia-Gonzalez A, Villa-Manzano AI, Lopez-Olivo MA, Salazar-Páramo M, González-Valera I, Gámez-Nava JI, García-González G, Ornelas-Torres JC, Gonzalez-López L, Cardona-Muñoz EG. Comparison in serum levels of procollagen aminoterminal propeptides I and III in patients with systemic lupus erythematosus 18(29), 2003. e-Pub 2003.
Morales-Romero J, Lopez-Olivo MA, Villa-Manzano AI, García-González A, Hernandez-Romo JA, Gámez-Nava JI, Gonzalez-López L. Pain and perception of difficulty for the sexual relation: factors of risk for depression in rheumatoid arthritis 18(34), 2003. e-Pub 2003.
Lopez-Olivo MA, Gonzalez-López L, Gámez-Nava JI, Salazar-Páramo M, García-González A, Villa-Manzano AI, Cota Sánchez AR. Serum homocysteine levels in patients with rheumatoid arthritis 18(52), 2003. e-Pub 2003.
Villa-Manzano Al, Garcia-Gonzalez A, Gonzalez-López L, Lopez-Olivo MA, Salazar-Paramo M, Gonzalez-Valera I, Galvan-Ramirez ML, Ornelas-Torres JC, Garcia-Gonzalez G, Gamez-Nava JI. Comparison in serum levels of procollagen aminoterminal propeptides I and III in patients with rheumatoid arthritis and spondilytis ankylosing 18(13), 2003. e-Pub 2003.
Garcia Gonzalez A, Gonzalez López L, Ornelas Aguirre JM, Morales Romero J, Al VM, Lopez-Olivo MA, Games Nava JI. Quality of life predictors in patients with rheumatoid arthritis 17(69), 2002. e-Pub 2002.
Garcia-Gonzalez A, Gonzalez-López L, Ornelas-Aguirre JM, Morales-Romero J, Villa-Manzano AI, Lopez-Olivo MA, Gamez-Nava JI. Predictors of quality of life in patients with ankylosing spondylitis 17(69), 2002. e-Pub 2002.
Bruera S, Bowman S, Ferguson K, Maliekel M, Lopez-Olivo MA, Suarez-Almazor M, Danila MI, Yazdany J, Agarwa S. Telemedicine for under-resourced patients with systemic lupus erythematosus: a qualitative study exploring the views and experiences of patients and rheumatology health care professionals. ACR Convergence 2024.
Negrón JB, Lopez-Olivo MA, Carmona L, Ingegnoli F, Zamora NV, Gamez- JI, Nava, Gonzalez-Lopez L, Goel N, Westrich-Robertson T, Christensen R, Suarez-Almazor ME. The advocacy effect: including caregivers or nearest support persons in research to better understand patient outcomes in rheumatoid arthritis. A qualitative study. Pan-American Congress of Rheumatology.

Book Chapters

Lopez-Olivo MA. Patient education and shared decision-making. In: Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy. Springer, Cham, 335-352, 2021.
Suarez-Almazor ME, Lopez-Olivo MA, Ortiz Z. Epidemiología clínica de las enfermedades reumáticas. In: Reumatologia, 2010.
Lopez-Olivo MA, Suarez-Almazor ME. Esclerosis sistemica y epidemiologia. In: Esclerosis Sistemica. 1, 1-15, 2009.
Lopez-Olivo MA, Suarez-Almazor ME. Evaluaciones económicas de los antagonistas del factor de necrosis tumoral alfa en la espondilitis anquilosante. In: Espondilitis anquilosante y otras espondiloartritis. Permanyer Publications, 2009.
Lopez-Olivo MA, Suarez-Almazor ME. Costo-efectividad de la terapia biologica en las enfemedades reumaticas. In: Teraia biologica en las enfermedades reumaticas. 1. Francisco Ramos Niembro, Javier Orozco-Alcala, 291-305, 2006.

Less

Grant & Contract Support

Date:	2023 - 2028
Title:	Methods Training for Comparative Effectiveness Research in Cancer
Funding Source:	NIH/NCI
Role:	Co-I
ID:	R25CA257883

Date:	2023 - 2028
Title:	Patterns of E-cigarette use and attitudes among cancer survivors
Funding Source:	Survivorship IRG
Role:	PI

Date:	2021 - 2025
Title:	Effects of Biologic and Targeted Therapies for Rheumatoid Arthritis on Cancer Outcomes
Funding Source:	NIH/NIAMS
Role:	Co-I
ID:	5R01AR078484

Date:	2020 - 2026
Title:	Improving decision-making in patients with resectable melanoma and pre-existing autoimmune disease considering immune checkpoint inhibition
Funding Source:	NIH/NCI
Role:	PI
ID:	K08CA237619

CV information above last modified April 30, 2025

Maria A. Lopez-Olivo, M.D., M.Sc., Ph.D.

Present Title & Affiliation

Primary Appointment

Research Interests

Education & Training

Degree-Granting Education

Postgraduate Training

Experience & Service

Academic Appointments

Other Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Professional Memberships

Selected Publications

Peer-Reviewed Articles

Manuals, Teaching Aids, Other Teaching Publications

Abstracts

Book Chapters

Grant & Contract Support

Patient Reviews

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Help #EndCancer

Maria A. Lopez-Olivo, M.D., M.Sc., Ph.D.

Present Title & Affiliation

Primary Appointment

Research Interests

Education & Training

Degree-Granting Education

Postgraduate Training

Experience & Service

Academic Appointments

Other Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Professional Memberships

Selected Publications

Peer-Reviewed Articles

Manuals, Teaching Aids, Other Teaching Publications

Abstracts

Book Chapters

Grant & Contract Support

Patient Reviews

Request an Appointment

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Volunteer